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We investigated the different patterns of neurodegeneration and glia activation in CA1
and CA3 hippocampal areas of TgCRND8 mice. The main feature of this transgenic
model is the rapid development of the amyloid pathology, which starts already at
3 months of age. We performed immunohistochemical analyses to compare the
different sensibility of the two hippocampal regions to neurodegeneration. We performed
qualitative and quantitative evaluations by fluorescence immunohistochemistry with
double or triple staining, followed by confocal microscopy and digital image analysis
in stratum pyramidale (SP) and stratum radiatum (SR) of CA1 and CA3, separately. We
evaluated time-dependent Aβ plaques deposition, expression of inflammatory markers,
as well as quantitative and morphological alterations of neurons and glia in transgenic
mice at 3 (Tg 3M) and 6 (Tg 6M) months of age, compared to WT mice. In CA1 SR
of Tg 6M mice, we found significantly more Medium and Large plaques than in CA3.
The pattern of neurodegeneration and astrocytes activation was different in the two
areas, indicating higher sensitivity of CA1. In the CA1 SP of Tg 6M mice, we found
signs of reactive astrogliosis, such as increase of astrocytes density in SP, increase of
GFAP expression in SR, and elongation of astrocytes branches. We found also common
patterns of glia activation and neurodegenerative processes in CA1 and CA3 of Tg 6M
mice: significant increase of total and reactive microglia density in SP and SR, increased
expression of TNFα, of iNOS, and IL1β in astrocytes and increased density of neurons–
astrocytes–microglia triads. In CA1 SP, we found decrease of volume and number of
pyramidal neurons, paralleled by increase of apoptosis, and, consequently, shrinkage of
CA1 SP. These data demonstrate that in TgCRND8 mice, the responses of neurons and
glia to neurodegenerative patterns induced by Aβ plaques deposition is not uniform in
the two hippocampal areas, and in CA1 pyramidal neurons, the higher sensitivity may
be related to the different plaque distribution in this area. All these modifications may be
at the basis of memory loss, the peculiar symptom of AD, which was demonstrated in
this transgenic mouse model of Aβ deposition, even at early stages.
Keywords: Alzheimer’s disease, microglia, astrocytes, TNF-α, IL1β, iNOS, apoptosis, confocal
immunohistochemistry
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INTRODUCTION
It is known that the pyramidal neurons of Cornu Ammonis
1 (CA1) of the hippocampus are highly sensible to insults
such as ischemia, inflammation, hypoglycemia, or excitotoxicity
(Whittington and Little, 1993; Prendergast et al., 2000a,b), as
compared to CA3 and dentate gyrus (Bramlett et al., 1999;
Kristensen et al., 2001; Lahtinen et al., 2001). While some
researchers explain the higher sensitivity of CA1 neurons to
the unique network properties of the hippocampal formation
(Lahtinen et al., 2001) and others to the higher density of
NMDA receptors in this region (Martens et al., 1998), the
exact mechanisms that underlie this region-specific selective
vulnerability are still not well understood. Neurons are the
basic functional units of the central nervous system, but it is
becoming more and more evident that glia cells are not only
supportive elements, but proper functioning of the neuron-
astrocyte-microglia triad is necessary for the correct organization
of the brain (Barres, 2008; Allen and Barres, 2009; Cerbai et al.,
2012; Lana et al., 2014, 2016, 2017). Emerging evidence indicates
that inflammation and other insults can modify the neuron–
astrocyte–microglia interactions (Cerbai et al., 2012; Lana et al.,
2014, 2016, 2017), and this mechanism may be involved not only
in brain aging but also in AD (Mercatelli et al., 2016).
Several studies have shown that microglia cells have
a functional role in coordinating the responses between
the immunity system and cognitive functions. During
development and adulthood, microglia are critical to maintain
microenvironmental homeostasis (Prinz and Priller, 2014), to
perform pruning of synapses, to phagocytose apoptotic neurons
and debris, and to maintain astrocyte functions (Fetler and
Amigorena, 2005; Fitzner et al., 2011; Paolicelli et al., 2011;
Schafer et al., 2012; Boche et al., 2013; Kettenmann et al.,
2013; Parkhurst et al., 2013; Schafer and Stevens, 2013; Wake
et al., 2013; Safaiyan et al., 2016). Different acute or chronic
neuroinflammatory or neurodegenerative conditions can cause
rapid recruitment of microglia to the site of injury, with resultant
functions characteristic of macrophages, such as phagocytosis,
antigen presentation, and release of immunomodulatory factors
resident responses (Hanisch and Kettenmann, 2007; Prinz
et al., 2011; Prinz and Priller, 2014). In the last few years,
the original definition of microglia activation as a stereotypic
harmful process has been disputed and revised. It is now clear
that microglia respond with a variety of different reactions
by integrating multifarious inputs, and microglia responses
may induce neuroprotective or neurotoxic effects, depending
upon the stimulus. Microglia cells are distributed throughout
the brain but have differential region-specific distribution,
and a wide range of morphologies in the various brain areas,
such as in CA1 and CA3 of the hippocampus (Lawson et al.,
1990). This heterogeneity may cause unequal sensitivity to
microglia-mediated neurotoxicity and/or neuroprotection in
different regions of the brain (Lawson et al., 1990). Astrocytes are
cells that in physiological conditions provide trophic support to
neurons. The idea that increased astrocytes is always a negative
phenomenon is rapidly changing, giving way to the new concept
of a more complex and more variegated role of astrocytes in
different neuropathological disorders (Sofroniew, 2009; Hamby
and Sofroniew, 2010; Verkhratsky et al., 2013; Burda and
Sofroniew, 2014). Dysfunction in the process of astrogliosis
causes loss of normal functions, increase of damaging effects,
and is considered one of the causes of damaging mechanisms
in the central nervous system (De Keyser et al., 2008; Farfara
et al., 2008; Sofroniew, 2009). As reported by Sofroniew (2009)
and Sofroniew and Vinters (2010), and further demonstrated
by Cerbai et al. (2012) and Lana et al. (2014, 2016, 2017),
astrogliosis is recently considered not a uniform process, nor
synonymous with formation of scar tissue. In CA3 hippocampus,
moderate reactive astrogliosis is found, with scarce proliferation
of astrocytes that do not form scars but occupy non-overlapping
domains (Bushong et al., 2002; Lana et al., 2016). Indeed,
contribution of astrocytes to the pathophysiology of the brain
is more complex than previously considered and glia responds
with multiple cellular phenotypes that are neuroprotective at
first and rarely only purely deleterious. Indeed, adaptive reactive
astrogliosis may be beneficial for neurons, while suppression
of astrocytes reactivity may increase neuronal vulnerability,
may alter neuronal regeneration and exacerbate pathology
(Sofroniew, 2009; Burda and Sofroniew, 2014; Pekny et al., 2014).
In mouse models of AD, it has been demonstrated not
only increase of reactive astrocytes, especially around Aβ
plaques (Bellucci et al., 2006; Giovannini et al., 2008; Rodriguez
et al., 2009) but also decrease of the size of astrocytes and
reduction of the number of primary branches (Olabarria et al.,
2010; Yeh et al., 2011; Schitine et al., 2015). Nevertheless,
astrocyte atrophy and astrogliosis in AD do not seem to occur
in all brain regions to the same extent, and the possibility
that astrocytes respond differently to the same stimulus in
different regions of the brain, causing different outcomes on
neuronal viability must be taken into consideration. Astrocytes
have many fundamental roles in the brain, such as the
trophic support to neurons, and significantly contribute to
active mnesic-associated processes, including synaptic plasticity
(Verkhratsky et al., 2011). Normally activated microglia are
important as the scavenger cells of the CNS. However,
proliferation and activation of microglia around Aβ plaques
is a prominent feature of Alzheimer’s disease (AD) and
impaired uptake and clearance of Aβ could increase the
risk of developing AD (Wang et al., 2015). Indeed, when
microglia fail responding to their normal regulatory feedback
and/or they show an impaired ability to clear Aβ (Paresce
et al., 1997; von Bernhardi, 2007), glial cells could become
predominantly cytotoxic. Microglia in aged brains may have
dystrophic, fragmented morphology, suggesting that AD may
develop when the neuroprotective microglia function is reduced
(Streit et al., 2004, 2009). There is also plenty of evidence
that unbridled microglia activity can be harmful to neurons in
neurodegenerative disease such as AD (Hamelin et al., 2016).
Switching polarization of microglia within appropriate time
windows may produce therapeutic benefits to neurodegenerative
diseases.
The hippocampus, one of the brain areas involved in the
mechanisms of memory (Fortin et al., 2002; Lana et al., 2013;
Giovannini et al., 2015; Squire et al., 2015), is one of the regions
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most affected by neurodegeneration in AD. In this research we
studied and compared the quantitative, temporal, and spatial
modifications of the interplay between astrocytes–microglia and
neurons in CA1 and CA3 hippocampus of TgCRND8 mice, a
mouse model of Aβ deposition, in comparison to WT littermates.
Our investigation focused on changes in areas CA1 and CA3
of the hippocampus because of their critical role in memory
processing and because of the significant functional, structural,
and morphological alterations in AD (Padurariu et al., 2012).
A better understanding of the role of astrocytes and microglia
in CA1 and CA3 regions may shed light on the mechanisms of
neurodegeneration.
MATERIALS AND METHODS
TgCRND8 mice
The TgCRND8 (Tg) mice express two mutated human APP
genes implicated in AD (Swedish, KM670/672NL and Indiana,
V717F) under the regulation of Syrian hamster prion promoter
gene (Chishti et al., 2001). The mice were maintained on a
hybrid (C57)/(C57/CH3) background by crossing transgenic
heterozygous TgCRND8 males with wild-type (WT) female
mice.
The main feature of this model is the very rapid development
of amyloid deposition in the brain. Mice display amyloid plaques
in the cortex and hippocampus already at 3 months of age
(Chishti et al., 2001) since the two mutations involve both the
β and γ secretase APP cleavage sites. These neuropathologic
manifestations are accompanied by impaired acquisition and
learning deficits (Chishti et al., 2001; Bellucci et al., 2006).
The transgenic mice were generated and supplied by Dr. P.
St George Hyslop (Center for Research in Neurodegenerative
Diseases, Toronto, Canada), and the colony was bred in our
animal house facility (Ce.S.A.L., Centro Stabulazione Animali
da Laboratorio), University of Florence. All animal experiments
were performed according to the Italian Law on Animal Welfare
(DL 26/2014), approved by the Institutional Animal Care and
Use Committee of the University of Florence and by the
Italian Ministry of Health. All efforts were made to minimize
animal sufferings and to use only the number of animals
necessary to produce reliable scientific data. Two groups of
transgenic mice were used: 3 months (n = 6, equally divided
for sex) and 6 months old (n = 6, equally divided for sex).
WT mice of 3 and 6 months of age (n = 6, equally divided
for sex and age were used); since no significant differences
were ever observed in any of the parameters investigated,
the data from the two groups were averaged and used as
controls.
At the appropriate ages (3 and 6 months), mice were deeply
anesthetized with Zoletil (80 mg/kg i.p.) and were perfused
transcardially with 200 ml of ice-cold paraformaldehyde solution
(4% paraformaldehyde in phosphate-buffered saline, PBS, pH
7.4). After overnight post fixation and cryoprotection (18%
sucrose/PBS), 40 µm-thick coronal sections were cut with a
cryostat and stored at −20◦C in anti-freeze solution until
immunohistochemistry.
Immunohistochemistry
Immunohistochemistry was performed with the free-floating
method (Giovannini, 2002; Lana et al., 2014) on mice brain
coronal sections containing the dorsal hippocampus (coordinates
−1.6 to −2.0 mm from bregma, Franklin and Paxinos, 2008).
The list of antibodies and their dilution is reported below. All the
washings were 3× 5 min.
Day 1
Free-floating sections (40 µm thick) were placed in wells of 24-
well plates and were rinsed in PBS-TX and blocked for 60 min
with BB (10% normal goat serum in PBS-TX and 0.05% NaN3).
Sections were then incubated overnight at 4◦C under slight
agitation with a combination of two primary antibodies, both
dissolved in BB.
Day 2
For double immunostaining, after washings, the sections were
incubated for 2 h at room temperature in the dark with
AlexaFluor 488-conjugated donkey anti-rabbit IgG secondary
antibody diluted in BB and then for 2 h at room temperature in
the dark with AlexaFluor 488-conjugated donkey anti-rabbit IgG
secondary antibody plus AlexaFluor 555 goat anti-mouse both
diluted 1:400 in BB.
For triple immunostaining, after washings, the sections
were incubated for 2 h at room temperature in the dark
with AlexaFluor 555 donkey anti-mouse IgG (1:400) secondary
antibody diluted in BB and then for 2 h at room temperature
in the dark with AlexaFluor 555 donkey anti-mouse IgG (1:400)
plus either one of the following secondary antibodies: AlexaFluor
635 goat anti-rabbit IgG (1:400). After washings, astrocytes were
immunostained using a mouse anti-GFAP antibody conjugated
with the fluorochrome AlexaFluor 488, dilution 1:500, while
neurons were immunostained with mouse anti-NeuN antibody
conjugated with the fluorochrome AlexaFluor 488, dilution 1:500.
After extensive washings, the sections were mounted onto
gelatin-coated slides using Vectashield with DAPI (Vector
Laboratories).
Slices were observed under an epifluorescent microscope or a
confocal laser scanning microscope (see below).
Antibodies
The following primary antibodies were used. For β amyloid
plaques immunostaining: a rabbit anti-β amyloid 1-42 antibody,
dilution 1:150 (Product Code #8243P, Cell Signaling, Danvers,
MA, United States); a mouse anti-β amyloid 1-16 (6E10)
antibody, dilution 1:400 (Product Code #SIG-39320, Covance,
Emeryville, CA, United States). For neurons: a mouse anti-
neuronal nuclei (NeuN) antibody, dilution 1:200 (Product
Code #MAB377, Millipore, Billerica, MA, United States); a
mouse anti-NeuN antibody conjugated with the fluorochrome
AlexaFluor 488, dilution 1:500 (Product Code #MAB377X,
Millipore, Billerica, MA, United States). For astrocytes: a rabbit
anti-glial fibrillary acidic protein (GFAP) antibody, dilution
1:500 (Product Code #Z0334, Dako Cytomation, Glostrup,
Denmark); a mouse anti-GFAP antibody conjugated with the
fluorochrome AlexaFluor 488, dilution 1:500 (Product Code
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#MAB3402X, Millipore, Billerica, MA, United States). For
total microglia: a rabbit anti-ionized calcium binding adaptor
molecule 1 (IBA1) antibody, dilution 1:300 (Product Code
#016-20001, WAKO, Osaka, Japan). For reactive microglia:
a mouse anti-CD68 antibody, dilution 1:100 (Product code
#Ab955, AbCam, Cambridge, United Kingdom). For apoptotic
cells: a mouse anti-cytochrome C (Cyt C) antibody, dilution
1:200 (Product Code #556432, Becton and Dickinson, Franklin
Lakes, NJ, United States). For TNF-α: a rabbit anti-TNF-α
antibody, dilution 1:500 (Product Code #PA5-19810, Thermo
Fisher Scientific, Waltham, MA, United States). For iNOS: a
rabbit anti-iNOS antibody, dilution 1:150 (Product Code #PA3-
030A, Thermo Fisher Scientific). For IL1β: a rabbit anti- IL1β
(Product code #Ab9722, AbCam, Cambridge, United Kingdom).
The following fluorescent secondary antibodies were used:
AlexaFluor 488 donkey anti-rabbit, dilution 1:400 (Product Code
#A21206, Thermo Fisher Scientific); AlexaFluor 555 donkey
anti-mouse, dilution 1:400 (Product Code #A31570, Thermo
Fisher Scientific); AlexaFluor 635 goat anti-rabbit, dilution 1:400
(Product Code #A31577, Thermo Fisher Scientific). Nuclei were
stained using DAPI, contained in the mounting medium for glass
slides, Vectashield (Product Code #H1200, Vector Laboratories,
Burlingame, CA, United States).
Protocol Used
Microscopy Techniques and Quantitative Analysis
Epifluorescence and confocal microscopy acquisitions were
performed in the regions of interest (ROIs, SP, and SR of
CA1 and CA3 dorsal hippocampus, separately) to acquire
immunofluorescence signals. The ROIs were the proximal region
for CA1 as defined by Masurkar (2018) and area CA3 as defined
by Lorente and de Nó (1934), Li et al. (1994), and Amaral and
Lavenex (2007).
The epifluorescence microscopy images were obtained with an
Olympus BX63 microscope equipped with a Metal Halide Lamp
(Prior Scientific Instruments Ltd., Cambridge, United Kingdom)
and a digital camera Olympus XM 10 (Olympus, Milan, Italy).
The confocal microscopy images were obtained with a
LEICA TCS SP5 confocal laser scanning microscope (Leica
Microsystems CMS GmbH, Mannheim, Germany. The
parameters of acquisition were maintained constant: frame
dimension 1240× 1240 points, frequency of acquisition 200 Hz.
Two experimenters performed all quantitative analyses blind,
and data were averaged. All evaluations of cell density were
made on z projections of 10 consecutive confocal scans (total
thickness 15 µm). Cells were counted, and the area of analysis
was measured. Cells were expressed as density (number/mm2).
We performed the following quantitative analyses using
ImageJ software (National Institute of Health1) separately in the
stratum pyramidale (SP) and stratum radiatum (SR) of CA1 and
CA3.
Density of cells (neurons, astrocytes, microglial cells, TNF-α,
iNOS, and IL1β-positive cells) was calculated as cells/mm2 in SP
and SR of CA1 and CA3, on confocal z projections of five scans
(total 7.5 µm inside the section).
1http://rsb.info.nih.gov/ij
Aβ load was calculated as total plaque density in SP or SR of
CA1 and CA3 (plaques/mm2). Plaques were further subdivided
by size into Small (S, below 2500 µm3), Medium (M, between
2500 and 7000 µm3), and large (L, over 7000 µm3) and counted
in SP or SR of CA1 and CA3.
For the evaluation of the volume of pyramidal neurons, we
considered the neuron as a spheroid. We measured the x and y
axes of five neurons chosen randomly in three different confocal
planes equally spaced in the depth of the sections (total 30
cells/animal in CA1 and CA3, separately). The volumes of the
cells were calculated, and data were averaged.
For the evaluation of the thickness of CA1 and CA3 SP layers,
the cell layer was measured at three fixed, equidistant locations
taken in three different confocal planes equally spaced in the
depth of the sections (total nine measures in CA1 and CA3,
separately), and data were averaged.
For the evaluation of the density of apoptotic neurons in CA1
and CA3 SP, every neuron (identified by NeuN immunostaining)
with a diffuse and intense Cyt C cytoplasmatic immunostaining
was considered “apoptotic” (Suen et al., 2008).
For the evaluation of the length of astrocytes branches, the
length of three principal branches of five astrocytes randomly
chosen was measured in three different confocal planes, equally
spaced in the depth of the sections (total 30 cells/animal in CA1
and CA3, separately), and data were averaged.
For the evaluation of the expression of GFAP and TNF-
α immunofluorescence, the following protocol was used: a z
projection of 10 consecutive confocal z scansions was done
(total thickness 15 µm). Selecting an appropriate threshold of
intensity of GFAP and TNF-α immunofluorescence, z-projection
was converted in a black and white image using ImageJ (care
was taken to maintain a fixed threshold value among sections).
Black and white pixels are points of fluorescence intensity above
or under the selected threshold, respectively. The ratio between
the number of black pixels and the area of analysis (mm2) in
each section was calculated, taken as quantitative expression
of GFAP and TNF-α immunofluorescence, and reported on
graphs.
For the evaluation of the volume of reactive microglia, we
considered the body of CD68-positive microglia as a spheroid.
We measured the x and y axes of 30 reactive microglia
cells/animal chosen randomly in a z-projection of 10 consecutive
confocal z-scans (total thickness 15 µm). The volumes of the
cells were calculated, and data were averaged. Spatial orientation
of IBA1+ microglia toward plaques was calculated counting
the microglial cells with soma contacting the surface of Large
plaque plus those with their soma located within 10 µm
around Large plaques, as percent of total microglia cells in the
ROIs.
For the evaluation of the density of the neuron–astrocyte–
microglia triads, we defined “triads” any cluster of cells in which
a neuron is in direct contact with a microglial cell (undergoing
phagocytosis) and one (or more than one) astrocytes take
contact with the neuronal body with their branches, frequently
forming a scar around it. The evaluation was made on a z
projection of 10 consecutive confocal z scans (total thickness
15 µm).
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Statistical Analysis
Statistical comparisons were performed using Graph
Pad Prism (Graph Pad Software Inc., La Jolla, CA,
United States) by Student’s t-test, one-way ANOVA followed
by Newman–Keuls multiple comparison test (if more than
two groups were compared), two-way ANOVA and three-
way ANOVA followed by Bonferroni post test, or linear
regression analysis, as appropriate. Significance was set at
P < 0.05.
RESULTS
Quantitative Analysis of Aβ Plaques
Deposition in CA1 and CA3
Hippocampus of TgCRND8 Mice and
Evaluation of Glial Response
We visualized the plaques by immunohistochemistry using
an anti Aβ1-42 antibody (green) in hippocampal sections
of TgCRND8 at 3 (Tg 3M) and 6 months of age (Tg 6M).
No plaques were ever found in CA1 and CA3 hippocampus
of WT mice. Images of fluorescent immunostaining were
taken in CA1 (Figures 1A,B) and CA3 hippocampal
regions (Figures 1E,F) with confocal microscopy and the
quantitative analysis of the density of Aβ (plaques/mm2) was
performed separately in Str. Pyramidale (SP) and Str. Radiatum
(SR).
The panels in Figures 1A,B,E,F show the images of plaques
(green) in CA1 SP and SR and CA3 SP and SR, respectively.
Quantitative analysis showed that in CA1 SP (65.8 ± 19.2
plaques/mm2) and SR (247.9 ± 101 plaques/mm2) of Tg 6M,
the density of Aβ plaques was significantly higher than in SP
(1.0 ± 0.4 plaques/mm2) and SR (10.1 ± 7.8 plaques/mm2) of
Tg 3M, respectively. The statistical analysis was performed by
Student’s t-test in CA1 SP (P < 0.05, Tg 6M vs. Tg 3M; Tg 3M:
n = 4; Tg 6M: n = 4) and in CA1 SR (P < 0.05, Tg 6M vs. Tg 3M;
Tg 3M: n = 4; Tg 6M: n = 4).
Quantitative analysis showed that in CA3 SP (62.4 ± 28.3
plaques/mm2) and SR (134.5 ± 46.8 plaques/mm2) of Tg 6M,
the density of Aβ plaques was significantly higher than in SP
(0.5 ± 0.25 plaques/mm2) and SR (0.5 ± 0.25 plaques/mm2) of
Tg 3M. The statistical analysis was performed by Student’s t-test
in CA2 SP (P < 0.05, Tg 6M vs. Tg 3M; Tg 3M: n = 4; Tg 6M:
n = 4) and in CA3 SR (Student’s t-test: ∗P < 0.05, Tg 6M vs. Tg
3M; Tg 3M: n = 4; Tg 6M: n = 5).
The plaques were then further characterized and quantified
subdividing them by size into small (S, less than 2500 µm3),
medium (M, between 2500 and 7000 µm3), and large (L, more
than 7000 µm3) in SP or SR of CA1 and CA3, as shown in
Figures 1C,D,G,H. Two-way ANOVA statistical analysis on Aβ
plaques in CA1 SP of Tg 3M and Tg 6M revealed a significant
main effect for experimental group [F(1,18) = 7.156, P < 0.05],
no significant effect for plaque size [F(2,18) = 1.084, P > 0.05],
and Interaction [F(2,18) = 1.084, P > 0.05]. Bonferroni post
test showed that small plaques (S) in CA1 SP of Tg 6M were
significantly more numerous than in Tg 3M (∗P < 0.05 Tg 6M S
vs. Tg 3M S). Two-way ANOVA statistical analysis on Aβ plaques
in CA1 SR of Tg 3M and Tg 6M revealed a significant main
effect for experimental group [F(1,18) = 45.69, P < 0.001], no
significant effect for plaque size [F(2,18) = 0.003925, P > 0.05],
and Interaction [F(2,18) = 0.1647, P > 0.05]. Bonferroni post
test showed that small (S), medium (M), and large plaques (L)
in CA1 SR of Tg 6M were significantly more numerous than
in Tg 3M (∗∗P < 0.01 Tg 6M S, M, L vs. Tg 3M S, M, L).
Two-way ANOVA statistical analysis on Aβ plaques in CA3 SP
of Tg 3M and Tg 6M revealed a significant main effect for
experimental group [F(1,18) = 10.04, P > 0.01], plaque size
[F(2,18) = 6.774, P > 0.01], and Interaction [F(2,18) = 6.774,
P > 0.01]. Bonferroni post test showed that small plaques (S)
in CA3 SP of Tg 6M were significantly more numerous than in
Tg 3M (∗∗∗P < 0.01 Tg 6M S vs. Tg 3M S). Two way ANOVA
statistical analysis on Aβ plaques quantification in CA3 SR of Tg
3M and Tg 6M revealed a significant main effect for experimental
group [F(1,18) = 13.36, P < 0.01], plaque size [F(2,18) = 3.965,
P< 0.05], and Interaction [F(2,18) = 3.965, P< 0.05]. Bonferroni
post test showed that Small plaques (S) in CA3 SR of Tg 6M were
significantly more numerous than in Tg 3M (∗∗P < 0.01 Tg 6M S
vs. Tg 3M S).
Statistical analysis with three-way ANOVA with Plaque Size,
ROI, and Age as the three variables was performed between
CA1 SP and CA3 SP of Tg 3M and Tg 6M. Results showed a
significant main effect for Age [F(1,47) = 18.01, P < 0.001], for
Size [F(2,47) = 7.77, P < 0.01], and for Interaction Age × Size
(F(2,47) = 7.77, P< 0.01). Bonferroni post test showed that Small
plaques (S) in CA3 SP of Tg 6M were on average significantly
more numerous than in CA1 SP of Tg 6M mice (P < 0.05),
while Medium (M) and Large (L) plaques were not significantly
different.
Statistical analysis with three way ANOVA with Plaque Size,
ROI, and Age as the three variables was performed between
CA1 SR and CA3 SR of Tg 3M and Tg 6M. Results showed
a significant main effect for ROI [F(1,47) = 13.16, P < 0.01],
Age [F(1,47) = 77.49, P < 0.001], for Interaction Age × ROI
[F(1,47) = 9.02, P < 0.01], and for Interaction Age × Size
[F(2,47) = 3.63, P < 0.05]. Bonferroni post test showed that
Medium plaques (M) and Large plaques (L) in CA1 SR of Tg 6M
were on average significantly more numerous than in CA3 SR of
Tg 6M mice (P< 0.05), while Small plaques were not significantly
different.
We performed triple immunostaining of astrocytes with GFAP
(green), of microglia with IBA1 (red), and of plaques using an
Aβ1-16 antibody (blue) in area CA1 of a TgCRND8 mouse at
6 months of age. The confocal image of the triple immunostaining
in Figure 1I shows that Aβ plaques (Figure 1I3, asterisks)
were surrounded and infiltrated by many hypertrophic astrocytes
(Figure 1I1, arrows) and microglia cells (Figure 1I2, open
arrows). Astrocytes and microglia located more distantly from
the plaques were in a less reactive state.
We then performed a thorough investigation of the
quantitative, temporal, and spatial modifications of the interplay
between astrocytes–microglia and neurons in CA1 and CA3
hippocampus of TgCRND8 mice in comparison to WT
littermates.
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FIGURE 1 | Analysis of Aβ1-42 plaques in CA1 and CA3 of Tg 3M and Tg 6M mice, and their subdivision by size into Small (S), Medium (M), and Large (L). (A,B)
Representative confocal photomicrographs of Aβ1-42 immunostaining in plaques (green) in CA1 of a Tg 3M (A) and a Tg 6 M (B) mouse. Scale bar: 100 µm. (C,D)
Quantitative analysis of S, M, and L plaques CA1 SP (C) and SR (D) of Tg 3M and Tg 6M. S plaques were significantly more numerous in CA1 SP of Tg 6M, while in
CA1 SR of Tg 6M mice S, M, and L plaques were significantly more numerous than in Tg 3M mice. (E,F) Representative confocal photomicrographs of Aβ1-42
immunostaining in plaques (green) in CA3 of a Tg 3M (E) and a Tg 6M (F) mouse. Scale bar: 100µm. (G,H) Quantitative analysis of S, M and L plaques CA3 SP (G)
and SR (H) of Tg 3M and Tg 6M. S plaques were significantly more numerous in CA3 SP and CA3 SR of Tg 6M than in Tg 3M mice. (I–I3) Representative confocal
photomicrographs of triple immunostaining of astrocytes [(I1), green], microglia [(I2), red], and Aβ plaques [(I3), blue] in CA1 of a Tg 6M (B) mouse. The merge is
shown in panel I. Scale bar: 40 µm. Data reported in all graph bars are expressed as mean ± SEM.
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Characterization of Astrocytes in CA1
and CA3 Hippocampus of TgCRND8
Mice
For qualitative and quantitative analyses, astrocytes were
visualized by immunohistochemistry with anti GFAP antibody
(green) in hippocampal sections of TgCRND8 at 3 (Tg 3M) and
6 months of age (Tg 6M), and of WT control mice. Images of
fluorescent immunostaining were taken in CA1 (Figures 2A–C)
and CA3 hippocampal regions (Figures 2G–I) with confocal
microscopy, separately. Figures 2A1–C1 show the magnification
of the framed areas in the SR of WT (A), Tg 3M (B), and Tg
6M (C) mice. We performed separately in CA1 and CA3 SP and
SR the qualitative and quantitative analyses to characterize the
astrocytes.
The graphs in Figures 2D–F show the results of the
quantitative analyses of astrocytes in CA1 SP (Figure 2D) and
SR (Figures 2E,F). We found that the density of astrocytes
significantly increased in SP of Tg mice both at 3 (+43%) and
6 months (+65%) of age in comparison to WT mice (Figure 2D)
[one-way ANOVA: F(2,14) = 10.69, P = 0.0015; Newman–Keuls
post-test: ∗∗P < 0.01 Tg 3M vs. WT, Tg 6M vs. WT; WT: n = 5;
Tg 3M: ns = 6; Tg 6M: n = 6]. Nevertheless, in CA1 SR, we
found no statistically significant difference of astrocytes density
among the three experimental groups [WT: 873.0 ± 3.74, Tg
3M: 912.9 ± 41.53, Tg 6M: 860.1 ± 36.24; One-way ANOVA:
F(2,14) = 0.615, P = 0.5543].
Qualitative analysis (Figures 2A1–C1) showed that in CA1 SR
of Tg 3M and Tg 6M astrocytes, although not more numerous
than in WT mice, had a different morphology from those present
in the SR of WT mice. We thus performed further analyses
on immunofluorescence intensity of GFAP and on the length
of primary astrocyte branches to compare the morphology of
astrocytes among the three experimental groups. We found
that GFAP immunofluorescence significantly increased, in CA1
SR of Tg 3M in comparison to WT mice (+33%), reaching a
plateau in CA1 SR of Tg 6M (+32%) (Figure 2E) [one-way
ANOVA: F(2,11) = 19.26, P = 0.0003; Newman–Keuls post-test:
∗∗∗P < 0.001 Tg 3M vs. WT, Tg 6M vs. WT; WT: n = 4; Tg
3M: n = 6; Tg 6M: n = 4]. Also, primary branches of astrocytes
in CA1 SR of Tg 6M were significantly longer (+24%) than
in WT mice (Figure 2F) [one-way ANOVA: F(2,13) = 3.622,
P = 0.0562; Newman–Keuls post-test: ∗P < 0.05 Tg 6M vs. WT;
WT: n = 4; Tg 3M: n = 6; Tg 6M: n = 4]. Also, primary branches of
astrocytes in CA1 SR of Tg 3M (+17%) and Tg 6M (+32%) were
both significantly longer than in WT mice (Figure 2F) [one-way
ANOVA: F(2,12) = 9.819, P = 0.003; Newman–Keuls post-test:
∗P < 0.05 Tg 3M vs. WT; ∗∗P < 0.01 Tg 6M vs. WT; WT: n = 5;
Tg 3M: n = 6; Tg 6M: n = 4].
On the contrary, in CA3, no statistically significant differences
were detected in the density of astrocytes in transgenic mice SP at
both 3 months (+8% vs. WT) and 6 months (+5% vs. WT) of age
(Figure 2J) [one-way ANOVA: F(2,14) = 0.089, P = 0.09150, n.s.;
WT: n = 5; Tg 3M: n = 6; Tg 6M: n = 6]. In addition, the expression
of GFAP protein in astrocytes of CA3 SR was only slightly but
not significantly increased at both 3 months (+13% vs. WT) and
6 months (+8% vs. WT) of age (Figure 2K) [one-way ANOVA:
F(2,9) = 0.570, P = 0.5843, n.s.; WT: n = 5; Tg 3M: n = 4; Tg 6M:
n = 3].
In CA3 SR, we found no statistically significant difference of
astrocytes density among the three experimental groups [WT:
1308.0 ± 68.30, Tg 3M: 901.8 ± 106.2, Tg 6M: 1023.0 ± 198.8;
one-way ANOVA: F(2,15) = 1.675, P = 0.2205, n.s.]. The length
of astrocyte branches in CA3 SR of transgenic mice was not
statistically different from WT mice at both 3 months (−3%)
and 6 months (−5%) of age (Figure 2L) [one-way ANOVA:
F(2,12) = 0.2175, P = 0. 8076, n.s..; WT: n = 5; Tg 3M: n = 6;
Tg 6M: n = 4].
We compared the results obtained in CA1 to those obtained in
CA3 by two-way ANOVA with ROIs and experimental groups as
the two variables. The statistical analysis on SP astrocytes density
revealed that in WT animals there was no significant difference
between CA1 and CA3 SP while a significant increase was found
in CA1 SP of Tg 3M and Tg 6M. Indeed, we found a significant
main effect for ROIs [(F(1,28) = 55.69, P < 0.001], experimental
groups [F(2,28) = 6.626, P < 0.01], and a significant Interaction
[F(2,28) = 5.077, P < 0.05]. Bonferroni post test showed that
astrocytes density in CA1 SP of Tg 3M (P < 0.001 vs. CA3 SP)
and Tg 6M (P < 0.001 vs. CA3 SP) was significantly higher than
in CA3 SP.
The statistical analysis on GFAP immunofluorescence
revealed that in WT animals, there was no significant difference
between CA1 and CA3 SR while a significant increase was found
in CA1 SR of Tg 3M and Tg 6M. Indeed, we found a significant
main effect for ROIs [F(1,20) = 29.66, P < 0.001], experimental
groups [F(2,20) = 7.654, P < 0.01], while the Interaction was not
significant [F(2,20) = 2.437, n.s.]. Bonferroni post test showed
that GFAP immunofluorescence in CA1 SR of Tg 3M (P < 0.01
vs. CA3 SR) and Tg 6M (P < 0.01 vs. CA3 SR) was significantly
higher than in CA3 SR.
The statistical analysis on the length of primary astrocytes
branches revealed that in WT and Tg 3M animals there was
no significant difference between CA1 and CA3 SR while a
significant increase was found in CA1 SR of Tg 6M. Indeed, we
found a significant main effect for Interaction [F(2,24) = 6.044,
P < 0.01]. Bonferroni post test showed that the length of primary
astrocytes branches in CA1 SR of Tg 6M was significantly higher
than in CA3 SR (P < 0.05).
Quantitative Analysis of Total and
Reactive Microglia in CA1 and CA3
Hippocampus of TgCRND8 Mice
To perform the quantitative analysis of total microglia on
hippocampal sections of TgCRND8 (Tg 3M, Tg 6M) and
control mice (WT), we immunolabelled microglia with anti
IBA1 antibody. Images of fluorescent immunostaining were
taken in CA1 (Figures 3A–C) and CA3 hippocampal regions
(Figures 3F–H) with confocal microscopy. Figures 3A1–C1
show the magnification of the framed areas in the SR of WT (A),
Tg 3M (B), and Tg 6M (C) mice. The quantitative analyses of total
microglia were performed in CA1 and CA3 SP and SR, separately.
The graphs in Figures 3D,E show the results of the
quantitative analyses of the density of IBA1+ microglia in CA1
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FIGURE 2 | Analysis of astrocytes in CA1 and CA3 of WT, Tg 3M, and Tg 6M. (A–C1) Representative confocal photomicrographs of GFAP immunostaining of
astrocytes (green) in CA1 of a WT (A), a Tg 3M (B), and a Tg 6M (C). Scale bar: 100 µm. panels (A1–C1) shows the magnification of astrocytes framed in panels
(A–C). Scale bar: 15 µm. (D) Quantitative analysis of GFAP-positive astrocytes/mm2 in CA1 SP of WT, Tg 3M, and Tg 6M. Astrocytes were significantly more
numerous in CA1 SP of Tg 3M and Tg 6M vs. WT mice. (E) Quantitative analysis of intensity of GFAP staining in CA1 SR of WT, Tg 3M, and Tg 6M. Intensity of GFAP
(Continued)
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FIGURE 2 | Continued
staining was significantly increased in CA1 SR of Tg 3M and Tg 6M vs. WT mice. (F) Length of principal astrocyte branches in CA1 SR of WT, Tg 3M, and Tg 6M.
Astrocytes branches were significantly longer in CA1 SR of Tg 3M and Tg 6M than in WT mice. (G–I) Representative confocal photomicrographs of GFAP
immunostaining of astrocytes (green) in CA3 of a WT (G), a Tg 3M (H), and a Tg 6M (I). Scale bar: 100 µm. (J) Quantitative analysis of GFAP-positive
astrocytes/mm2 in CA3 SP of WT, Tg 3M, and Tg 6M. There are no significant differences in SP of Tg 6M and Tg 3M vs. WT mice. (K) Quantitative analysis of
intensity of GFAP staining in CA3 SR of WT, Tg 3M, and Tg 6M. There are no significant differences in SR of Tg 3M and Tg 6M vs. WT mice. (L) Length of principal
astrocyte branches in CA3 SR of WT, Tg 3M, and Tg 6M. There are no significant differences in SR of Tg 3M and Tg 6M vs. WT mice. Data reported in all graph bars
are expressed as mean ± SEM.
SP and CA1 SR. In CA1 SP of Tg 6M, we found a slight (+35%),
although not statistically significant, increase of the density of
IBA1+ microglia in comparison to WT mice (Figure 3D) [one-
way ANOVA: F(2,14) = 1.252, P = 0.3161, n. s.; WT: n = 6;
Tg 3M: n = 5; Tg 6M: n = 6]. However, the density of IBA1+
microglia in CA1 SR of Tg 6M significantly increased both
in comparison to WT and to Tg 3M (+72% vs. WT; +43%
vs. Tg 3M; Figure 3E) [one-way ANOVA: F(2,13) = 11.23,
P = 0.0015; Newman–Keuls post-test: ∗∗P < 0.01 Tg 6M vs. WT,
##P < 0.01 Tg 6M vs. Tg 3M; WT: n = 6; Tg 3M: n = 5; Tg 6M:
n = 5].
In CA3 SP of Tg 6M mice, we found a statistically significant
increase of the density of IBA1+ microglia in comparison both to
WT and Tg 3M mice (+46% vs. WT;+43% vs. Tg 3M; Figure 3I)
[one-way ANOVA: F(2,13) = 6.217, P = 0.0127; Newman–Keuls
post-test: ∗P < 0.05 Tg 6M vs. WT, #P < 0.05 Tg 6M vs. Tg 3M;
WT: n = 6; Tg 3M: n = 5; Tg 6M: n = 5]. IBA1+ microglia density
increased also in CA3 SR of Tg 6M and the effect was statistically
significant both from WT and Tg 3M mice (+48% vs. WT;
+51% vs. Tg 3M; Figure 3J) [one-way ANOVA: F(2,13) = 5.570,
P = 0.0179; Newman–Keuls post-test: ∗P < 0.05 Tg 6M vs. WT,
#P < 0.05 Tg 6M vs. Tg 3M; WT: n = 6; Tg 3M: n = 5; Tg 6M:
n = 5].
Two-way ANOVA analysis demonstrated that IBA1+
microglia density was not significantly different in CA1 SP and
SR in comparison to CA3 SP and SR of all groups examined.
We studied the spatial orientation of IBA1+ microglia toward
Large plaques calculating the percent microglia cells located on
or within 10 µm around Large plaques in CA1 and CA3 SR (see
dotted line in Figure 3K which shows a Large plaque in blue
and microglia cells in green). Quantitative analysis showed that
in CA1 and CA3 SR of TG 6M mice a highly significant percent
of microglia was oriented toward Large plaques in comparison
to TG 3M (∗∗P < 0.01, Tg 6M vs. Tg 3M, Student’s t-test,
Figures 3L,M). Two-way ANOVA analysis demonstrated that the
orientation of IBA1+ microglia toward Large plaques was not
significantly different in CA1 SR in comparison to CA3 SR of all
groups examined.
To visualize reactive microglia, we performed the
immunolabeling with anti CD68 antibody, a marker of
reactive microglia cells, on hippocampal sections of TgCRND8
(Tg 3M, Tg 6M) and control mice (WT). Images of fluorescent
immunostaining were taken in CA1 (Figures 4A–C) and CA3
hippocampal regions (Figures 4G–I) with confocal microscopy
and the quantitative analysis of the density of reactive microglia
was performed in CA1 and CA3 SP and SR, separately.
Figures 6A1–C1 show the magnification of the framed areas in
the SR of WT (A), Tg 3M (B), and Tg 6M (C) mice.
The graphs in Figures 4D,E show the results of the
quantitative analyses of reactive microglia in CA1 SP and
CA1 SR, respectively. In CA1 SP of Tg 3M and Tg 6M, the
density of reactive microglia increased (+82 and +347% vs. WT,
respectively) although not significantly, in comparison to WT
mice (Figure 4D) [one-way ANOVA: F(2,14) = 1.395, P = 0.2802,
n. s.; WT: n = 6; Tg 3M: n = 5; Tg 6M: n = 6]. On the contrary,
in CA1 SR of Tg 6M, we found a highly significant increase of
the density of microglia in comparison both to WT and Tg 3M
mice (+902% vs. WT; +636 vs. Tg 3M; Figure 4E) [one-way
ANOVA: F(2,13) = 10.77, P = 0.0017; Newman–Keuls post-test:
∗∗P < 0.01 Tg 6M vs. WT, ##P < 0.01 Tg 6M vs. Tg 3M; WT:
n = 6; Tg 3M: n = 5; Tg 6M: n = 5]. We evaluated the volume
of reactive microglia in CA1 SR, and we found a statistically
significant increase of the average volume of CD68+ microglia
in CA1 SR both at 3 (+487% vs. WT) and 6 months (+626% vs.
WT) of age, in comparison to WT mice (Figure 4F) [one-way
ANOVA: F(2,14) = 13.84, P = 0.0005; Newman–Keuls post-test:
∗∗P< 0.01 Tg 3M vs. WT, ∗∗∗P< 0.001 Tg 6M vs. WT; WT: n = 6;
Tg 3M: n = 5; Tg 6M: n = 6].
Results obtained in CA3 (Figures 4J–L) are in accordance
with those in CA1. In CA3 SP, we found a statistically significant
increase of the density of reactive microglia in Tg 6M in
comparison to WT and Tg 3M mice (+1448% vs. WT;+339% vs.
Tg 3M; Figure 4J) [one-way ANOVA: F(2,14) = 4.002, P = 0.0422;
Newman–Keuls post-test: ∗P < 0.05 Tg 6M vs. WT; WT: n = 6;
Tg 3M: n = 5; Tg 6M: n = 6]. In addition, in CA3 SR of Tg 6M
mice reactive microglia significantly increased in comparison to
WT (+3395%) (Figure 4K) [one-way ANOVA: F(2,13) = 4.244,
P = 0.0381; Newman–Keuls post-test: ∗P < 0.05 Tg 6M vs. WT;
WT: n = 6; Tg 3M: n = 5; Tg 6M: n = 5]. The evaluation of
the volume of reactive microglia in CA3 SR showed that there
was a statistically significant increase of the average volume of
CD68+ microglia in CA3 SR at 6 months (434% vs. WT) of
age, in comparison to WT mice (Figure 4L) [one-way ANOVA:
F(2,14) = 8.350, P = 0.0041; Newman–Keuls post-test: ∗∗P < 0.01
Tg 6M vs. WT, #P < 0.05 Tg 6M vs. Tg 3M; WT: n = 6; Tg 3M:
n = 5; Tg 6M: n = 6].
Two-way ANOVA analysis demonstrated that the CD68+
microglia density was not significantly different in CA1 SP and
SR in comparison to CA3 SP and SR of all groups examined.
Analysis of Inflammatory Mediators in
CA1 and CA3 Hippocampus of TgCRND8
Mice
To verify whether different expression of inflammatory mediators
might be present in CA1 and CA3, we first performed
Frontiers in Aging Neuroscience | www.frontiersin.org 9 November 2018 | Volume 10 | Article 372
fnagi-10-00372 November 9, 2018 Time: 16:26 # 10
Ugolini et al. Neurodegeneration Patterns in TgCRND8 Mice
FIGURE 3 | Analysis of total microglia in CA1 and CA3 of WT, Tg 3M, and Tg 6M. (A–C) Representative confocal photomicrographs of IBA1 immunostaining of
microglia (green) in CA1 of a WT (A), a Tg 3M (B), and a Tg 6M (C). Scale bar: 100 µm. Panels (A1–C1) shows the magnification of microglial cells framed in panels
(A–C). Scale bar: 20 µm. (D,E) Quantitative analysis of microglia/mm2 in CA1 SP (D) and SR (E) of WT, Tg 3M, and Tg 6M. Microglia cells are significantly more
numerous in CA1 SR of Tg 6M mice vs. WT and Tg 3M. (F–H) Representative confocal photomicrographs of IBA1 immunostaining of microglia (green) in CA3 of a
WT (F), a Tg 3M (G), and a Tg 6M (H). Scale bar: 100 µm. (I,J) Quantitative analysis of microglia/mm2 in CA3 SP (I) and SR (J) of WT, Tg 3M, and Tg 6M. Microglia
cells are significantly more numerous in SP and SR of Tg 6M mice vs. WT and Tg 3M. (K) Representative confocal image of microglia cells (green) spatially oriented
toward a Large Aβ1-42 plaque (blue). The dotted line represents the area used for the quantitative analysis of spatially oriented microglia. Scale bar: 20 µm. (L,M)
Quantitative analysis of spatially oriented microglia in CA1 SR (L) and CA3 SR (M), represented as microglia located on or within 10 µm around Large plaques (area
enclosed in the dotted line in panel K expressed as percent of total microglia. In both CA1 and CA3 SR of Tg 6M mice, the percent of microglia spatially oriented
toward Large plaques was significantly higher than in Tg 3M. Data reported in all graph bars are expressed as mean ± SEM.
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FIGURE 4 | Analysis of reactive microglia in CA1 and CA3 of WT, Tg 3M, and Tg 6M. (A–C) Representative confocal photomicrographs of CD68 immunostaining of
reactive microglia (red) in CA1 of a WT (A), a Tg 3M (B), and a Tg 6M (C). Scale bar: 100 µm. Panels (A1–C1) shows the magnification of reactive microglial cells
framed in panels (A–C). Scale bar: 20 µm. (D,E) Quantitative analysis of reactive microglia/mm2 in CA1 SP (D) and CA1 SR (E) of WT, Tg 3M, and Tg 6M. Microglia
cells are significantly more numerous in CA1 SR of Tg 6M mice vs. WT and Tg 3M. (F) Measure of reactive microglia cells volume in CA1 SR (F) of WT, Tg 3M, and
(Continued)
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FIGURE 4 | Continued
Tg 6M. Reactive microglia cells volume was significantly increase in Tg 6M and Tg 3M vs. WT. (G–I) Representative confocal photomicrographs of CD68
immunostaining of reactive microglia (red) in CA3 of a WT (G), a Tg 3M (H), and a Tg 6M (I). Scale bar: 100 µm. (J,K) Quantitative analysis of microglia/mm2 in CA3
SP (J) and SR (K) of WT, Tg 3M and Tg 6M. Microglia cells are significantly more numerous in SP and SR of Tg 6M mice vs. WT. (L) Measure of reactive microglia
cells volume in CA3 SR (L) of WT, Tg 3M, and Tg 6M. Reactive microglia cells volume was significantly increase in Tg 6M vs. WT. Data reported in all graph bars are
expressed as mean ± SEM.
immunofluorescence staining with anti TNF-α antibody on
hippocampal sections of TgCRND8 (Tg 3M, Tg 6M) and
control mice (WT). Neurons were counterstained with anti-
NeuN antibody. Images of fluorescent immunostaining were
taken in CA1 (Figures 5A–C) and CA3 hippocampal regions
(Figures 5F–H) with confocal microscopy and the quantitative
analysis of the density of TNF-α-positive cells was performed in
CA1 and CA3 SR, separately.
In CA1 of transgenic mice, TNF-α immunostaining
increased and was localized mainly in astrocyte-like cells
evenly scattered throughout the SR. To identify unequivocally
the type of TNF-α-positive cells, we performed a double
staining immunohistochemistry with anti TNF-α and anti GFAP
antibodies. In CA1 SR of transgenic mice, we found a near
complete colocalization of TNF-α in GFAP-positive astrocytes.
Figures 5D–D2 show a group of TNF-α-positive astrocytes in the
CA1 SR of a Tg 6M mouse. It is evident that all GFAP-positive
astrocytes (D1, red) express TNF-α (D2, green), as evidenced by
the yellow-orange color in Figure 5D. The graph in Figure 5E
shows the results of the quantitative analysis of TNF-α-positive
cells in CA1 SR. We found a significant increase of density of
TNF-α-positive cells in CA1 SR in Tg 6M (+410% vs. WT)
in comparison to WT [one-way ANOVA: F(2,13) = 8.712,
P = 0.0040; Newman–Keuls post-test: ∗∗P < 0.01 Tg 6M vs. WT,
#P < 0.05 Tg 6M vs. Tg 3M; WT: n = 6; Tg 3M: n = 6; Tg 6M:
n = 5]. In Tg 3M, we found a slight, not significant increase of
TNF-α-positive cells in comparison to WT (+187% vs. WT).
In CA3 SR of transgenic mice, TNF-α immunostaining
increased. The double staining immunohistochemistry with
anti TNF-α (Figure 5I2, green), and anti GFAP antibodies
(Figure 5I1, red) revealed that in CA3 SR of transgenic mice all
GFAP-positive astrocytes expressed TNF-α as evidenced by the
yellow-orange color in Figure 5I. TNF-α-positive astrocytes were
quantified in CA3. The results showed that the density of TNF-
α-positive astrocytes significantly increased in CA3 SR of Tg 6M
in comparison to WT and to Tg 3M (+1646% vs. WT; +393%
vs. Tg 3M) (Figure 5J) [one-way ANOVA: F(2,12) = 4.454,
P = 0.0358; Newman–Keuls post-test: ∗P < 0.05 Tg 6M vs. WT,
#P < 0.05 Tg 6M vs. Tg 3M; WT: n = 6; Tg 3M: n = 6; Tg 6M:
n = 3]. In CA3 SR, other structures, mainly located toward the
DG were also TNF-α positive (Figure 5I2).
We compared the results obtained in CA1 to those obtained
in CA3 by two-way ANOVA with ROIs and experimental groups
as the two variables.
The statistical analysis on the density of TNF-α-positive cells
revealed that in WT animals there was no significant difference
between CA1 and CA3 SR while a significant increase was found
in CA1 SR of Tg 3M and Tg 6M. Indeed, we found a significant
main effect for ROIs [F(1,25) = 16.04, P < 0.001], experimental
groups [F(2,25) = 13.94, P< 0.001], but no significant Interaction
[F(2,25) = 1.326, n.s.]. Bonferroni post test showed that astrocytes
density in CA1 SR of Tg 3M (P < 0.05 vs. CA3 SR) and Tg 6M
(P < 0.05 vs. CA3 SP) was significantly higher than in CA3 SR.
Immunofluorescence staining with anti iNOS antibody
(Figures 5K–K2, green) was performed on hippocampal sections
of TgCRND8 (Tg 3M, Tg 6M) and control mice (WT). Astrocytes
were counterstained with anti-GFAP antibody (Figures 5K,K1,
red) and neurons with anti NeuN antibody (not shown).
Images of fluorescent immunostaining were taken in CA1
(Figures 5K–K2) and CA3(not shown) hippocampal regions
with confocal microscopy and the quantitative analysis of the
density of iNOS-positive cells was performed in CA1 and CA3
SR, separately. Double labeling confocal microscopy with anti-
iNOS (Figure 5K2) and anti-GFAP (Figure 5K1) demonstrated
that in CA1 SR of Tg 6M iNOS was expressed GFAP-
positive astrocytes, as evidenced by the yellow-orange color in
Figure 5K (arrows). Double labeling confocal microscopy with
anti-iNOS and anti-GFAP demonstrated that in CA3 SR of
Tg 6M iNOS was expressed in GFAP-positive astrocytes (not
shown).
We found a significant increase of iNOS expression in cells in
CA1 SR of Tg 3M (+51%) and of Tg 6M (+66%) in comparison
to WT. The statistical analysis was performed on the density of
iNOS-positive cells in CA1 SR [one-way ANOVA: F(2,13) = 5.12,
P = 0.0268; Newman–Keuls post-test: ∗P < 0.05 Tg 3M and,
∗P < 0.05 Tg 6M vs. WT; WT: n = 5; Tg 3M: n = 4; Tg 6M: n = 5;
Figure 5L].
We found a significant increase of iNOS expression in cells of
CA3 SR of Tg 3M (+58%), while in Tg 6M iNOS expression in
cell was not different from control values (+1%) in comparison
to WT mice. The statistical analysis was performed on the
density of iNOS-positive cells in CA3 SR [one-way ANOVA:
F(2,11) = 8.762, P = 0.0077; Newman–Keuls post-test: ∗P < 0.05
Tg 3M vs. Tg 6M and WT; WT: n = 4; Tg 3M: n = 4; Tg 6M: n = 4;
Figure 5M].
Both in CA1 SR and CA3 SR iNOS was also expressed in
neurons, but the effect was not different from WT mice (data not
shown).
We compared the results obtained in CA1 to those obtained
in CA3 by two-way ANOVA with ROIs and experimental groups
as the two variables.
The statistical analysis on the density of iNOS-positive cells
revealed that in WT and Tg 3M animals there was no significant
difference between CA1 and CA3 SR while a significant increase
was found in CA1 SR of Tg 6M. We found a significant main
effect for ROIs (F(1,20) = 25.23, P < 0.001), experimental groups
(F(2,20) = 6.513, P < 0.01), and for Interaction (F(2,20) = 3.540,
P < 0.05). Bonferroni post test showed that the density of
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FIGURE 5 | Analysis of TNF-α cellular expression in CA1 and CA3 of WT, Tg 3M, and Tg6M. (A–C) Representative confocal photomicrographs of TNF-α
immunostaining (green) and NeuN immunostaining of neurons (red) in CA1 of a WT (A), a Tg 3M (B), and a Tg 6M (C). Scale bar: 100 µm. (D–D2) Double staining
immunohistochemistry with anti TNF-α (green) and anti GFAP (red) antibodies. In CA1 SR we obtained a near complete colocalization of TNF-α on astrocytes
(GFAP-positive cells). Scale bar: 25 µm. (E) Quantitative analysis of TNF-α+ cells/mm2 in CA1 SR. TNF-α+ cells were significantly more numerous in SR of Tg 6M
(Continued)
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FIGURE 5 | Continued
vs. WT mice. (F–H) Representative confocal photomicrographs of TNF-α immunostaining (green) and NeuN immunostaining of neurons (red) in CA3 of a WT (H), a
Tg 3M (I), and a Tg 6M (J). Scale bar: 100 µm. (I–I2) Double staining immunohistochemistry with anti TNF-α (green) and anti GFAP (red) antibodies in CA3 SR of Tg
6M mice. We found partial colocalization of TNF-α in astrocytes. Scale bar: 25 µm. (J) Quantitative analysis of TNF-α+ cells/mm2 in CA3 SR. TNF-α+ cells were
significantly more numerous in SR of Tg 6M vs. WT mice. (K–K2) Double staining immunohistochemistry with anti iNOS (green) and anti GFAP (red) antibodies in
CA1 SR of Tg 6M mice. We found colocalization of iNOS in astrocytes. Scale bar: 25 µm. (L) Quantitative analysis of iNOS+ cells/mm2 in CA1 SR. iNOS+ cells were
significantly more numerous in SR of Tg 3M and Tg 6M vs. WT mice. (M) Quantitative analysis of iNOS+ cells/mm2 in CA3 SR. iNOS+ cells were significantly more
numerous in SR of Tg 3M vs. WT mice. (N–N2) Double staining immunohistochemistry with anti IL1β (green) and anti GFAP (red) antibodies in CA1 SR of Tg 6M
mice. We found colocalization of IL1β in astrocytes. Scale bar: 25 µm. (O) Quantitative analysis of IL1β+ cells/mm2 in CA1 SR. IL1β+ cells were significantly more
numerous in SR of Tg 6M vs. WT mice. (P) Quantitative analysis of IL1β+ cells/mm2 in CA3 SR. IL1β+ cells were significantly more numerous in SR of Tg 6M vs. WT
mice.
iNOS-positive in CA1 SR of Tg 6M was significantly higher than
in CA3 SR (P < 0.001).
Immunofluorescence staining with anti IL1β antibody
(Figures 5N,N2, green) was performed on hippocampal sections
of TgCRND8 (Tg 3M, Tg 6M) and control mice (WT). Astrocytes
were counterstained with anti-GFAP antibody (Figures 5N,N1,
red) and microglia with anti-CD68 antibody (not shown).
Images of fluorescent immunostaining were taken in CA1
(Figures 5N–N2) and CA3 hippocampal regions (not shown)
with confocal microscopy and the quantitative analysis of the
density of IL1β-positive cells was performed in CA1 and CA3 SR,
separately. Double labeling confocal microscopy with anti-IL1β
(Figure 5N2) and anti-GFAP (Figure 5N1) demonstrated
that in CA1 SR of Tg 6M, IL1β was expressed in GFAP-
positive astrocytes, as evidenced by the yellow-orange color
in Figure 5N (arrows). Double labeling confocal microscopy
with anti-IL1β and anti-GFAP demonstrated that in CA3 SR
of Tg 6M, IL1β was expressed in GFAP-positive astrocytes (not
shown).
We found a slight increase of IL1β expression in cells in CA1
SR of Tg 3M (+25%, not significant) and a significant increase
in CA1 SR of Tg 6M (+83%) in comparison to WT mice. The
statistical analysis was performed on the density of IL1β-positive
cells in CA1 SR [one-way ANOVA: F(2,11) = 5.733, P = 0.0248;
Newman–Keuls post-test: ∗P < 0.05 Tg 6M vs. WT; WT: n = 4;
Tg 3M: n = 3; Tg 6M: n = 5; Figure 5O].
We found a slight significant increase of IL1β expression in
cells of CA3 SR of Tg 3M (+28%, not significant), while in
Tg 6M, IL1β expression in cells was significantly higher than
in WT (+122%). The statistical analysis was performed on the
density of IL1β-positive cells in CA3 SR [one-way ANOVA:
F(2,11) = 4.730, P = 0.0394; Newman–Keuls post-test: ∗P < 0.05
Tg 6M vs. WT; WT: n = 4; Tg 3M: n = 3; Tg 6M: n = 5;
Figure 5P].
Two-way ANOVA analysis demonstrated that IL1β expression
in cells was not significantly different in CA1 SR in comparison
to CA3 SR of all groups examined.
Both in CA1 SR and CA3 SR, IL1β was also expressed in
microglia, but the effect was not different from WT mice (data
not shown).
Characterization of Neurons in CA1 and
CA3 Pyramidal Layers in TgCRND8 Mice
We evaluated the time-course of the extent of damage of
CA1 and CA3 pyramidal neurons in Tg mice using the
immunohistochemical staining of neurons with anti NeuN
antibody (red) on hippocampal sections of TgCRND8 mice at
3 (Tg 3M) and 6 months of age (Tg 6M) and of WT control
mice. Images of fluorescent immunostaining were taken in CA1
(Figures 6A–C) and CA3 hippocampal regions (Figures 6H–J)
with confocal microscopy and the quantitative analyses of the
density (Figure 6D) and the volume of pyramidal neurons
(Figure 6F), and of thickness of the pyramidal layer (Figure 6E)
were performed.
The graphs in Figures 6D–F show the results of the
quantitative analyses in CA1. The density of neurons was
significantly lower in CA1 SP of Tg mice at 3 (−15% vs. WT)
and 6 months (−28% vs. WT) of age than in CA1 of WT mice
(Figure 6D) [one-way ANOVA: F(2,12) = 9.552, P = 0.0033;
Newman–Keuls post-test: ∗∗P < 0.01 Tg 6M vs. WT, ∗P < 0.05
Tg 3M vs. WT, #P < 0.05 Tg 6M vs. Tg 3M; WT: n = 5; Tg
3M: n = 6; Tg 6M: n = 4]. Consistently, we found a reduction
of CA1 SP thickness in 3 (−12%) and 6 months (−40%) old
Tg mice in comparison to WT mice (Figure 6E). The effect was
statistically significant at 6 months of age only [one-way ANOVA:
F(2,10) = 4.658, P = 0.0372; Newman–Keuls post-test: ∗P < 0.05
Tg 6M vs. WT; WT: n = 4; Tg 3M: n = 5; Tg 6M: n = 4]. Also, we
found a statistically significant reduction of the average volume of
CA1 pyramidal neurons both at 3 (−36% vs. WT) and 6 months
(−42% vs. WT) of age in comparison to WT mice (Figure 6F)
[one-way ANOVA: F(2,12) = 23.50, P < 0.0001; Newman–Keuls
post-test: ∗∗∗P < 0.001 Tg 3M vs. WT, Tg 6M vs. WT; WT:
n = 5; Tg 3M: n = 6; Tg 6M: n = 4]. Correlation analysis between
the number of CA1 Pyramidal neurons and the thickness of
CA1 Pyramidal layer is shown in the graph in Figure 6G. We
found a highly significant correlation between the two parameters
(∗∗P = 0.01, R2 = 0.5763; WT: n = 5; Tg 3M: n = 6; Tg 6M:
n = 4).
We analyzed the density of CA3 pyramidal neurons, their
volume and the thickness of CA3 SP. Surprisingly, the density of
CA3 pyramidal neurons in SP of Tg 3M and Tg 6M (−8% vs. WT,
Figure 6K) [one-way ANOVA: F(2,12) = 2.933, P = 0.0918, n.s.;
WT: n = 5; Tg 3M: n = 6; Tg 6M: n = 4] and the thickness of the
pyramidal layer (+19% vs. WT, Figure 6L) [one-way ANOVA:
F(2,12) = 1.897, P = 0.1923, n.s.; WT: n = 5; Tg 3M: n = 6;
Tg 6M: n = 4] were not significantly different from WT mice.
Also, the average volume of CA3 pyramidal neurons of transgenic
mice at 3 and 6 months of age was not significantly different
from WT mice (Figure 6M) [one-way ANOVA: F(2,12) = 1.268,
P = 0.3165, n.s.; WT: n = 5; Tg 3M: n = 6; Tg 6M: n = 4],
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FIGURE 6 | Analysis of neurons in CA1 and CA3 of WT, Tg 3M, and Tg 6M. (A–C) Representative confocal photomicrographs of NeuN immunostaining of neurons
(red) in CA1 of a WT (A), a Tg 3M (B), and a Tg 6M (C). Scale bar: 60 µm. (D) Quantitative analysis of neurons/mm2 in CA1 SP (D) of WT, Tg 3M, and Tg 6M.
Neurons were significantly less numerous in SP of Tg 6M and Tg 3M vs. WT mice. (E) Measure of thickness of CA1 SP (E) of WT, Tg 3M, and Tg 6M. Thickness of
CA1 SP was significantly reduced in Tg 6M vs. WT. (F) Measure of neurons volume in CA1 SP (F) of WT, Tg 3M, and Tg 6M. Neurons volume was significantly
reduced in Tg 6M and Tg 3M vs. WT. (G) Correlation analysis between number of CA1 SP neurons and CA1 SP thickness. There is a highly significative correlation.
(H–J) Representative confocal photomicrographs of NeuN immunostaining of neurons (red) in CA3 of a WT (H), a Tg 3M (I), and a Tg 6M (J). Scale bar: 60 µm.
(K) Quantitative analysis of neurons/mm2 in CA3 SP (K) of WT, Tg 3M, and Tg 6M. There are no significant differences in SP of Tg 6M and Tg 3M vs. WT mice.
(L) Measure of thickness of CA3 SP (L) of WT, Tg 3M, and Tg 6M. There are no significant differences in thickness of CA3 SP of Tg 6M and Tg 3M vs. WT.
(M) Measure of neurons volume in CA3 SP (M) of WT, Tg 3M, and Tg 6M. There are no significant differences in neurons volume in CA3 SP of Tg 6M and Tg 3M vs.
WT. Data reported in all graph bars are expressed as mean ± SEM.
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FIGURE 7 | Analysis of apoptotic neurons in CA1 and CA3 of WT, Tg 3M, and Tg 6M. (A–C1) Representative epifluorescence photomicrographs of Cyt C
immunostaining of apoptotic neurons (red) and NeuN immunostaining of neurons (green) in CA1 SP of WT (A,A1), a Tg 3M (B,B1), and a Tg 6M (C,C1). The arrows
in (A1–C1) point to apoptotic neurons in CA1 SP. Scale bar: 100 µm. (D–D2) Confocal magnification of apoptotic neurons in CA1 SP of a Tg 6M. Scale bar: 30 µm.
(E) Quantitative analysis of apoptotic neurons/mm2 in CA1 SP of WT, Tg 3M, and Tg 6M. Apoptotic pyramidal neurons were significantly more numerous in SP of Tg
3M and Tg 6M vs. WT mice. (F–H1) Representative epifluorescence photomicrographs of Cyt C immunostaining of apoptotic neurons (red) and NeuN
immunostaining of neurons (green) in CA3 SP of WT (F,F1), a Tg 3M (G,G1) and a Tg 6M (H,H1). The arrows in (F1–H1) point to apoptotic neurons in CA3 SP. Scale
bar: 100 µm. (I) Quantitative analysis of apoptotic neurons/mm2 in CA3 SP of WT, Tg 3M, and Tg 6M. There are no significant differences in SP of Tg 6M and Tg 3M
vs. WT mice. Data reported in all graph bars are expressed as mean ± SEM.
as shown by the statistical analysis, as shown by the statistical
analysis.
Quantitative Analysis of Apoptotic
Neurons in CA1 and CA3 Hippocampus
of TgCRND8 Mice
We performed a double staining immunohistochemistry with
anti Cyt C (red) and anti NeuN (green) antibodies on
hippocampal sections of TgCRND8 at 3 (Tg 3M) and 6 months
of age (Tg 6M) and of WT control mice. Images of fluorescent
immunostaining were taken in CA1 (Figures 7A–C,A1–C1)
and CA3 hippocampal regions (Figures 7F–H,F1–H1) with
epifluorescence microscopy. Figures 7D–D2 shows a Cyt
C-positive neuron (arrow) in CA1 SP at a higher magnification,
acquired with laser confocal microscopy.
We performed the quantitative analyses of apoptotic neurons
in CA1 and CA3 SP. We found a statistically significant
increase of density of apoptotic neurons in CA1 of Tg mice
at 3 (+129%) and 6 months (+82%) of age in comparison
to WT mice (Figure 7E) [one-way ANOVA: F(2,13) = 9.956,
P = 0.0024; Newman–Keuls post-test: ∗∗P < 0.01 Tg 3M vs. WT,
∗P < 0.05 Tg 6M vs. WT; WT: n = 4; Tg 3M: n = 6; Tg 6M:
n = 6].
The analysis of Cyt C-positive neurons performed in CA3 SP
showed a slight, not statistically significant increase at 6 months
of age (+36%) in comparison to WT mice, as shown by
qualitative (Figures 7F–H1) and quantitative analyses (Figure 7I)
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[one-way ANOVA: F(2,12) = 0.890, P = 0.4362, n.s.; WT: n = 4;
Tg 3M: n = 6; Tg 6M: n = 5].
We compared the results obtained in CA1 to those obtained
in CA3 by two-way ANOVA with ROIs and experimental groups
as the two variables.
Two-way ANOVA analysis demonstrated that apoptotic
neurons were not significantly different in CA1 SP in comparison
to CA3 SP of all groups examined (WT, Tg 3M, and Tg 6M).
Nevertheless, the percent increase of apoptotic neurons in CA1
SP of Tg 3M and Tg 6M was significantly higher than in CA3 SP
(see Table 1).
Analysis of Neuron–Astrocytes–Microglia
Triad in CA1 and CA3 Hippocampus of
TgCRND8 Mice
To evaluate the presence of neuron–astrocytes–microglia
triads in CA1 and CA3 SR, we performed triple staining
immunohistochemistry with anti-NeuN, anti-GFAP, and anti-
IBA1 antibodies on hippocampal sections of TgCRND8 (Tg
3M, Tg 6M) and control mice (WT). Images of fluorescent
immunostaining were taken in CA1 (Figures 8A–C) and CA3
(Figures 8D–F) hippocampal regions with confocal microscopy
and the quantitative analysis of the density of the triads was
performed in CA1 and CA3 SR. The presence of triads in CA1
and CA3 SR is shown qualitatively in Figures 8A–C and D,E,
respectively.
The Quantitative analysis of triads in CA1 SR is shown in the
graph in Figure 8G. We found a statistically significant increase
of triads density in CA1 SR of Tg 6M (+674%) in comparison
with WT mice [one-way ANOVA: F(2,8) = 12.66, P = 0.0033;
Newman–Keuls post-test: ∗∗P < 0.01 Tg 6M vs. WT, ##P < 0.01
Tg 6M vs. Tg 3M; WT: n = 3; Tg 3M: n = 4; Tg 6M: n = 4].
TABLE 1 | Differences between CA1 and CA3 in all parameters investigated.
Tg 3M Tg 6M
CA1 CA3 CA1 CA3
Density of astrocytes in SP +43 +8 +65∗∗ +5
Intensity of GFAP in SR +33 +13 +32 +8
Length of astrocyte branches in SR +17∗∗ −3 +32∗∗ −5
Density of IBA1+ microglia in SP +7 +2 +35 +46
Density of IBA1+ microglia in SR +1 −2 +72 +48
Density of CD68+ microglia in SP +82 +252 +347∗ +1,448
Density of CD68+ microglia in SR +36 +940 +902∗ +3,395
Volume of CD68+ microglia in SR +487∗ +170 +626 +434
Density of triads in SR +219 +111 +674∗∗ +170
Density of TNF-α+ cells in SR +187 +254 +410 +1646
iNOS +50.75 +58.86 +65.87∗ +1.342
IL1β +25.11 +28.38 +83.55 +122.5
Density of Cyt C+ neurons in SP +129∗∗∗ +10 +82 +36
Density of neurons in SP −15∗∗ +7 −28∗∗ −8
Volume of neurons in SP −36∗∗∗ +5 −42∗∗∗ +8
Thickness of SP −12∗∗ +19 −40∗ +3
All data represent percent differences from WT, taken as 100%. ∗P < 0.05;
∗∗P < 0.01; ∗∗∗P < 0.001 in comparison to CA3 (Student’s t-test).
In CA3 SR, we found a statistically significant increase of
triads density both in Tg 3M (+111%) and Tg 6M (+170%)
in comparison to WT mice (Figure 8H) [one-way ANOVA:
F(2,9) = 11.55, P = 0.0033; Newman–Keuls post-test: ∗P < 0.05
Tg 3M vs. WT, ∗∗P < 0.01 Tg 6M vs. WT; WT: n = 4; Tg 3M:
n = 4; Tg 6M: n = 4].
We compared the results obtained in CA1 to those obtained
in CA3 by two-way ANOVA with ROIs and experimental groups
as the two variables.
The statistical analysis on the density of triads revealed that
in WT and Tg 3M animals, there was no significant difference
between CA1 and CA3 SR while a significant increase was found
in CA1 SR of Tg 6M. Indeed, we found a significant main
effect for experimental groups [F(2,17) = 21.97, P < 0.001], and
for Interaction [F(2,17) = 5.134, P < 0.05], but not for ROIs
[F(1,17) = 3.148; n.s.]. Bonferroni post test showed that the
density of triads in CA1 SR of Tg 6M was significantly higher than
in CA3 SR (P < 0.01).
Comparisons Between CA1 and CA3
The most salient differences between CA1 and CA3 are reported
in Table 1. Each column represents the percent variation,
normalized to the control values found in WT mice, of each
parameter investigated in transgenic mice at 3 and 6 months
of age. The differences between the parameters investigated in
CA1 and CA3 at 3 or 6 months of age, were then evaluated
using the Student’s t-test. It is evident from the data in the table
that astrogliosis was higher in CA1, both in terms of density of
astrocytes and of length of astrocyte branches. The number of
IBA1-positive microglia did not vary significantly between the
two areas, while CD68+ microglia was more pronounced both in
SP and SR of CA3. TNF-α showed a very peculiar characteristic:
it was expressed by astrocytes in CA1 SR, while in CA3 it was
present not only in astrocytes but also in other structures. The
percent variation of iNOS was higher in CA1 SR at 3 months of
age, while that of IL1β varied similarly in CA1 and CA3 SR at 3
and 6 months of age. CA1 pyramidal neurons of transgenic mice
were significantly smaller and less numerous than those of WT
mice, causing significant shrinkage of CA1 stratum pyramidale.
On the contrary, CA3 Pyramidal neurons of transgenic mice
did not change significantly, neither in terms of number and
volume and did not show significant increase of apoptosis, even
at 6 months of age. The decrease of CA1 pyramidal neurons
possibly was caused, at least in part, by increase of apoptotic
mechanisms, which indeed were significantly more pronounced
in CA1 than in CA3 SP. Interestingly, neuron–astrocytes–
microglia triads were more numerous in CA1 SR than in CA3
SR. Astrocytes and microglia, forming triads with neurons, help
clearing apoptotic and degenerating neurons at higher degree in
CA1, in comparison to CA3.
DISCUSSION
Aim of the present study was to investigate and compare
the quantitative, temporal, and spatial modifications of the
interplay between astrocytes, microglia, and neurons in CA1 and
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FIGURE 8 | Characterization and quantification of the neuron-astrocyte-microglia triads in CA1 and CA3 SR of WT, TG 3M, and TG 6M mice. (A–C) Representative
confocal photomicrographs of triple immunostaining of neurons (NeuN, red), astrocytes (GFAP, green), and microglia (IBA1, blue) in the CA1 SR of a WT (A), a TG
3M (B), and of a TG 6M mouse (C). Scale bar: 40 µm. (D–F) Representative confocal photomicrographs of triple immunostaining of neurons (NeuN, red), astrocytes
(GFAP, green), and microglia (IBA1, blue) in the CA3 SR of a WT (D), a TG 3M (E), and of a TG 6M mouse (F). Scale bar: 40 µm. Examples of triads in Tg 3M and Tg
6M are shown in the framed areas (B,C,E,F). In WT mice (A–D), groups of neuron-astrocyte-microglia not considered as triads are pointed by arrows. (G,H)
Quantitative analysis of neuron-astrocyte-microglia triads/mm2 in CA1 (G) and CA3 (H) SR. Triads are significantly more numerous in CA1 SR of Tg 6M vs. WT mice.
In CA3 SR, triads are significantly more numerous in Tg 3M and Tg 6M than in WT mice. Data reported in all graph bars are expressed as mean ± SEM.
CA3 hippocampus of TgCRND8 mice, a mouse model of Aβ
deposition, at 3 and 6 months of age. The comparison between
these two hippocampal areas is fundamental and can help
explaining the more pronounced sensitivity of CA1 pyramidal
neurons to neurodegenerative insults, both in experimental
animals and in humans (Mueller et al., 2010; Small et al.,
2011; Bartsch et al., 2015). It is also important because of
the critical, although different, role of these areas in memory
processing and because of their significant functional, structural,
and morphological alterations in AD (Bartsch and Wulff, 2015).
Therefore, in this work, we studied the different patterns of
neuron degeneration and apoptosis, glia activation/modification,
as well as different expression of proinflammatory mediators,
at different stages of plaque deposition, subdividing the
hippocampus in the two main ROIs CA1 and CA3. The
principal findings of this study were that the two contiguous
and interconnected hippocampal regions of transgenic mice
display remarkably different cellular modifications and neuronal
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vulnerability to the deposition of Aβ plaques. Interestingly, while
Aβ load in CA1 was not significantly different from that of CA3,
both at 3 and 6 months of age, in CA1 SR of Tg 6M mice the
Medium and Large plaques were significantly more numerous
than in CA3 SR. As expected, we found many hypertrophic
astrocytes surrounding and infiltrating Aβ plaques, both in CA1
and CA3. Nevertheless, astrogliosis was also evident not only
close to the plaques, but also in the SR parenchyma far from
and devoid of plaques. Astrogliosis, evidenced by increased
recruitment of astrocytes, increased expression of GFAP and
elongation of astrocyte branches, significantly increased in the
entire CA1 of transgenic mice, mainly at 6 months of age, while
in CA3 it was significantly lower than in CA1. Healthy astrocytes
are indispensable for synaptogenesis, synaptic maintenance and
maturation (Pfrieger, 2009; Heneka et al., 2010), significantly
contributing to memory-associated processes (Verkhratsky et al.,
2011), but they are also involved in AD, as first suggested by Alois
Alzheimer (Alzheimer, 1910). The involvement of astrocytes
in AD progression is variegated, depending upon the brain
area interested and the gravity of the disease. Indeed, in the
hippocampus, progression of AD has been associated with an
early atrophy of astrocytes, defined clasmatodendrosis (Penfield,
1928; Hulse et al., 2001) that, at later stages of the disease, coexists
with reactive astrocytes around plaques (Olabarria et al., 2010;
Yeh et al., 2011). We never found clasmatodendrotic astrocytes
in CA1 and CA3 parenchyma of transgenic mice at both 3 and
6 months of age.
Dissecting the hippocampus in the two main regions CA1
and CA3 we observed significant differences in most of the
parameters investigated, at different stages of plaque deposition.
In CA1 SR of 6 months old transgenic mice, we found
significantly higher levels of the expression of the cytokines
TNF-α, IL1β, as well as iNOS in astrocytes, confirming our
and others’ results in TgCNRD8 mice (Luccarini et al., 2012)
and other models of neurodegenerative diseases (Deng et al.,
2014; Lana et al., 2017). It has been demonstrated that the
inflammatory cytokine TNF-α is usually expressed in the brain
by activated microglia, and, to a lesser extent, by activated
astrocytes and neurons (Perry et al., 2002). Nevertheless,
many studies have shown that the gradual deposition of Aβ
peptide and overproduction of inflammatory mediators activate
astrocytes, further inducing expression and release of cytokines,
interleukins, NO, and other proinflammatory mediators (Choi
et al., 2014; Heneka et al., 2015) that in turn increase pro-
apoptotic cascades in the surrounding brain areas (Luccarini
et al., 2012), and exacerbate AD pathology (Tan et al., 2007).
Furthermore, it has been demonstrated that TNF-α induces
apoptosis primarily through the activation of cell-surface TNF-
α type I receptors that contain death domains (Park et al.,
2007). In line with these data, our results demonstrate that
in CA1 SP, both at 3 and 6 months of age, a significant
number of pyramidal neurons underwent apoptosis, possibly
targeted by increased TNF-α expression and release by astrocytes.
In addition, stimulation of iNOS by cytokines in astrocytes
may cause increased concentrations of NO that can be toxic
to neurons. Indeed, iNOS is upregulated AD patients’ brain
(Vodovotz et al., 1996) and KO of iNOS is protective in mouse
models of AD (Nathan et al., 2005). These mechanisms may be
the cause of the significant loss of CA1 pyramidal neurons and
shrinkage of CA1 stratum pyramidale, evidenced in CA1 but not
in CA3.
It is known that Aβ plaques induce production and release of
pro-inflammatory cytokines by neurons and astrocytes (Hickman
et al., 2008; Daria et al., 2017) which, in turn, promote a shift
in microglia activity, from surveillance/maintenance mode, to
execution of immune tasks. Microglia can assume two different
phenotypic forms, M1 and M2 (Loane and Kumar, 2016).
While M1 microglia can express and release proinflammatory
cytokines (de Bilbao et al., 2009; Protti et al., 2013), M2
microglia is more active in the surveillance/maintenance of tissue
homeostasis, phagocytosing apoptotic or degenerating neurons,
preventing secondary inflammatory mechanisms and promoting
tissue regeneration (Hu et al., 2012; Suenaga et al., 2015). In
both CA1 and CA3 of transgenic mice, we found an increase
of total microglia, and of reactive microglia, corresponding
to the M1 phenotype, which significantly increased in CA1
SP and SR at 3 and 6 months of age. These data indicate
that the inflammatory milieu triggered by plaque deposition
caused increased recruitment of microglia cells, and significantly
increased its reactivity. Furthermore, in agreement with data
obtained by Bolmont et al. (2008) in the cortex of APPPS1
transgenic mice, we found significant spatial orientation of
microglia toward Large plaques, both in CA1 and CA3 SR of Tg
6M mice.
The reactivity state of microglia in CA1 SR, together with
increased astrogliosis, caused increased formation of neuron-
astrocytes-microglia triads. The concerted actions of astrocytes
and microglia in the formation of triads with neurons can
recognize “danger signals,” including cellular debris produced
from apoptotic or necrotic cells (Milligan and Watkins, 2009),
and can clear the damaged neurons or neuronal debris by
phagocytosis (Cerbai et al., 2012; Lana et al., 2014). Indeed,
we found several reactive microglia cells that cooperated with
astrocytes in the phagocytosis of degenerated neurons, mainly
in SR of transgenic mice. Under physiological conditions, the
effects of astrocytes and microglia are protective, removing
entire neurons by phagoptosis (Lana et al., 2017), clearing
dysfunctional synapses and controlling inflammation and the
diffusion of cellular damage to neighboring tissue. Also, activated
microglia contribute to Aβ clearance and removal of cytotoxic
debris from the nervous tissue. However, phagocytosis of
living healthy neurons by microglial in inflamed CNS has
also been reported (Neher et al., 2012; Vilalta and Brown,
2017). Furthermore, uninterrupted microglia activation may
exacerbate inflammation, increase Aβ deposition and intensify
neurodegeneration (Michaud and Rivest, 2015). Indeed, in AD,
as for astrocytes, pro-inflammatory and detrimental, or anti-
inflammatory and even protective properties have been attributed
to microglia (Mandrekar-Colucci and Landreth, 2010; Heneka
et al., 2015; Heppner et al., 2015). All these different findings
may suggest that microglia may acquire heterogeneous activation
states, or, as in our results, microglia can be protective or
detrimental, depending on the region where it is located and
other concauses.
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Here, we have demonstrated that not only the proximity
to plaques determines the development of a specific reactive
phenotype of microglia (Plescher et al., 2018) and astrocytes
(Olabarria et al., 2010), but also the different plaque size
and distribution within different brain areas. In CA1 and
CA3 hippocampus, although Aβ load was similar, plaque
organization in terms of dimensions was different, and glia and
neurons responded with differential patterns of activation and
neurodegeneration. The sensitivity of the subregional pyramidal
neurons to neurodegeneration was very different, at both 3
and 6 months of age. Our paper is in line with recent
evidence showing hippocampal subregional-specific patterns
of neurodegeneration at different stages of Aβ deposition
(Albuquerque et al., 2015; Mahar et al., 2017).
Significant progress has been made in understanding the
relationships of amyloid pathology to hippocampal dysfunctions;
however, complete understanding of this process across
hippocampal anatomical areas remains incomplete. Although
the hippocampus is often described as a unitary structure, this is
hardly the case. The unique molecular and synaptic milieu of its
spatial domains allow asking how AD pathophysiology can arise
in one region vs. the other one. Memory impairment, particularly
episodic and spatial memory, is the most important symptom of
AD, often related to the dysfunction of pyramidal neurons in
CA1 and entorhinal cortex (Hyman et al., 1984; West et al., 2000;
Scheff et al., 2007; Kerchner et al., 2010). Studies have shown that
lesions centering on CA1 are sufficient for memory impairment
(Zola-Morgan et al., 1986). Indeed, our data lend support to the
idea that Aβ load exerts greater effects on CA1 than on CA3.
Many authors found that the CA1 is the most vulnerable region
of the hippocampus to neuronal loss both in animal models of AD
and in AD patients (West et al., 2000; Price et al., 2001; Rossler
et al., 2002; Stepanichev et al., 2006; Corbett et al., 2013). Among
AD patients, variable degree of atrophy between CA1 and CA3
is often found, CA3 being the least damaged area (Hyman et al.,
1984; West et al., 1994). On the other hand, in different transgenic
mouse models of AD it has also been found (Gruart et al., 2008)
that learning, and memory deficits are not directly correlated to
Aβ load. Therefore, other factors, besides Aβ deposition may be
involved in memory deficits.
The loss of CA1 pyramidal neurons, which underwent
neuronal death by apoptosis, caused shrinkage of the CA1
pyramidal cell layer. All these modifications may be at the
basis of memory loss which was repeatedly demonstrated in
this transgenic mouse model of Aβ deposition, even at early
stages (Chishti et al., 2001; Hamm et al., 2017). Interestingly
however, it has been shown that increased physical activity
improves behavioral and cognitive deficits in murine models
of AD (García-Mesa et al., 2011) and reduces the risk of AD
in humans (Buchman et al., 2012). The precise mechanism of
action underlying the positive effects of physical activity are still
not known, but may involve astrocytes (Latimer et al., 2011),
indicating that astrogliosis may become a therapeutic target for
AD (Colangelo et al., 2014).
AUTHOR CONTRIBUTIONS
MG designed the research. FU, DL, PN, DN, and DP performed
the experiments. FU, DL, PN, DP, and MG analyzed the data. DL,
MG, and FC interpreted the results and the experiments. DL, MG,
FU prepared the figures. MG and DL drafted the manuscript. DL,
MG, FU, and FC edited and revised the manuscript. All authors
read and approved the final version of the manuscript.
FUNDING
DL is recipient of a fellowship from the Dean of
Università di Firenze. This work was funded by MIUR-PRIN
(2015E8EMCM_006, Giovannini) and by Università di Firenze
(Fondi Ateneo Ricerca Giovannini). I hereby declare that the
funding sources had no involvement in the conduct of the
research, in preparation of the article, in study design; in the
collection, analysis, and interpretation of data; in the writing
of the report; and in the decision to submit the article for
publication. None of the authors nor the institution at any time
received payment or services from a third party for any aspect of
the submitted work. No relationships or activities have influenced
what is written in the submitted work.
ACKNOWLEDGMENTS
We thank Dr. L. Tofani (Department of Neuroscience,
Psychology, Drug Research and Child Health, NEUROFARBA,
University of Florence) for help in three-way ANOVA statistical
analysis.
REFERENCES
Albuquerque, M. S., Mahar, I., Davoli, M. A., Chabot, J. G., Mechawar, N.,
Quirion, R., et al. (2015). Regional and sub-regional differences in hippocampal
GABAergic neuronal vulnerability in the TgCRND8 mouse model of
Alzheimer’s disease. Front. Aging Neurosci. 24:30. doi: 10.3389/fnagi.2015.00030
Allen, N. J., and Barres, B. A. (2009). Neuroscience: glia - more than just brain glue.
Nature 457, 675–677. doi: 10.1038/457675a
Alzheimer, A. (1910). “Beiträge zur Kenntnis der pathologischen Neuroglia und
ihrer Beziehungen zu den Abbauvorgängen im Nervengewebe,” in Histologische
und Histopathologische Arbeiten u ber die Grosshirnrinde mit Besonderer Beru
Cksichtigung der Pathologischen Anatomie der Geisteskrankheiten, eds F. Nissl
and A. Alzheimer (Jena: Gustav Fischer), 401–562.
Amaral, D. G., and Lavenex, P. (2007). “Hippocampal neuroanatomy,” in The
Hippocampus Book, eds P. Andersen, R. Morris, D. G. Amaral, and J. O’Keefe
(New York, NY: Oxford University Press), 37–114.
Barres, B. A. (2008). The mystery and magic of glia: a perspective on their roles in
health and disease. Neuron 60, 430–440. doi: 10.1016/j.neuron.2008.10.013
Bartsch, T., Döhring, J., Reuter, S., Finke, C., Rohr, A., Brauer, H., et al. (2015).
Selective neuronal vulnerability of human hippocampal CA1 neurons: lesion
evolution, temporal course, and pattern of hippocampal damage in diffusion-
weighted MR imaging. J. Cereb. Blood Flow Metab. 35, 1836–1845. doi: 10.1038/
jcbfm.2015.137
Bartsch, T., and Wulff, P. (2015). The hippocampus in aging and disease: from
plasticity to vulnerability. Neuroscience 309, 1–16. doi: 10.1016/j.neuroscience.
2015.07.084
Frontiers in Aging Neuroscience | www.frontiersin.org 20 November 2018 | Volume 10 | Article 372
fnagi-10-00372 November 9, 2018 Time: 16:26 # 21
Ugolini et al. Neurodegeneration Patterns in TgCRND8 Mice
Bellucci, A., Luccarini, I., Scali, C., Prosperi, C., Giovannini, M. G., Pepeu, G.,
et al. (2006). Cholinergic dysfunction, neuronal damage and axonal loss in
TgCRND8 mice. Neurobiol. Dis. 23, 260–272. doi: 10.1016/j.nbd.2006.03.012
Boche, D., Perry, V. H., and Nicoll, J. A. (2013). Review: activation patterns
of microglia and their identification in the human brain. Neuropathol. Appl.
Neurobiol. 39, 3–18. doi: 10.1111/nan.12011
Bolmont, T., Haiss, F., Eicke, D., Radde, R., Mathis, C. A., Klunk, W. E., et al.
(2008). Dynamics of the microglial/amyloid interaction indicate a role in plaque
maintenance. J. Neurosci. 28, 4283–4292. doi: 10.1523/JNEUROSCI.4814-07.
2008
Bramlett, H. M., Green, E. J., and Dietrich, W. D. (1999). Exacerbation of
cortical and hippocampal CA1 damage due to posttraumatic hypoxia following
moderate fluid-percussion brain injury in rats. J. Neurosurg. 91, 653–659. doi:
10.3171/jns.1999.91.4.0653
Buchman, A. S., Boyle, P. A., Yu, L., Shah, R. C., Wilson, R. S., and Bennett, D. A.
(2012). Total daily physical activity and the risk of AD and cognitive decline in
older adults. Neurology 78, 1323–1329. doi: 10.1212/WNL.0b013e3182535d35
Burda, J. E., and Sofroniew, M. V. (2014). Reactive gliosis and the multicellular
response to CNS damage and disease. Neuron 81, 229–248. doi: 10.1016/j.
neuron.2013.12.034
Bushong, E. A., Martone, M. E., Jones, Y. Z., and Ellisman, M. H. (2002).
Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical
domains. J. Neurosci. 22, 183–192. doi: 10.1523/JNEUROSCI.22-01-00183.2002
Cerbai, F., Lana, D., Nosi, D., Petkova-Kirova, P., Zecchi, S., Brothers, H. M., et al.
(2012). The neuron-astrocyte-microglia triad in normal brain ageing and in
a model of neuroinflammation in the rat hippocampus. PLoS One 7:e45250.
doi: 10.1371/journal.pone.0045250
Chishti, M. A., Yang, D. S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., et al.
(2001). Early-onset amyloid deposition and cognitive deficits in transgenic mice
expressing a double mutant form of amyloid precursor protein 695. J. Biol.
Chem. 276, 21562–21570. doi: 10.1074/jbc.M100710200
Choi, S. S., Lee, H. J., Lim, I., Satoh, J., and Kim, S. U. (2014). Human astrocytes:
secretome profiles of cytokines and chemokines. PLoS One 9:e92325. doi: 10.
1371/journal.pone.0092325
Colangelo, A. M., Alberghina, L., and Papa, M. (2014). Astrogliosis as a therapeutic
target for neurodegenerative diseases. Neurosci. Lett. 565, 59–64. doi: 10.1016/j.
neulet.2014.01.014
Corbett, N. J., Gabbott, P. L., Klementiev, B., Davies, H. A., Colyer, F. M.,
Novikova, T., et al. (2013). Amyloid-beta induced CA1 pyramidal cell loss in
young adult rats is alleviated by systemic treatment with FGL, a neural cell
adhesion molecule-derived mimetic peptide. PLoS One 8:e71479. doi: 10.1371/
journal.pone.0071479
Daria, A., Colombo, A., Llovera, G., Hampel, H., Willem, M., Liesz, A., et al. (2017).
Young microglia restore amyloid plaque clearance of aged microglia. EMBO J.
36, 583–603. doi: 10.15252/embj.201694591
de Bilbao, F., Arsenijevic, D., Moll, T., Garcia-Gabay, I., Vallet, P., Langhans, W.,
et al. (2009). In vivo over-expression of interleukin-10 increases resi stance to
focal brain ischemia in mice. J. Neurochem. 110, 12–22. doi: 10.1111/j.1471-
4159.2009.06098.x
De Keyser, J., Mostert, J. P., and Koch, M. W. (2008). Dysfunctional astrocytes as
key players in the pathogenesis of central nervous system disorders. J. Neurol.
Sci. 267, 3–16. doi: 10.1016/j.jns.2007.08.044
Deng, Y., Xie, D., Fang, M., Zhu, G., Chen, C., Zeng, H., et al. (2014).
Astrocyte-derived proinflammatory cytokines induce hypomyelination in the
periventricular white matter in the hypoxic neonatal brain. PLoS One 9:e87420.
doi: 10.1371/journal.pone.0087420
Farfara, D., Lifshitz, V., and Frenkel, D. (2008). Neuroprotective and neurotoxic
properties of glial cells in the pathogenesis of Alzheimer’s disease. J. Cell. Mol.
Med. 12, 762–780. doi: 10.1111/j.1582-4934.2008.00314.x
Fetler, L., and Amigorena, S. (2005). Neuroscience. Brain under surveillance: the
microglia patrol. Science 309, 392–393. doi: 10.1126/science.1114852
Fitzner, D., Schnaars, M., van Rossum, D., Krishnamoorthy, G., Dibaj, P.,
Bakhti, M., et al. (2011). Selective transfer of exosomes from oligodendrocytes
to microglia by macropinocytosis. J. Cell. Sci. 124, 447–458. doi: 10.1242/jcs.
074088
Fortin, N. J., Agster, K. L., and Eichenbaum, H. B. (2002). Critical role of the
hippocampus in memory for sequences of events. Nat. Neurosci. 5, 458–462.
doi: 10.1038/nn834
Franklin, K. B. J., and Paxinos, G. (2008). The Mouse Brain in Stereotaxic
Coordinates. New York, NY: Academic Press.
García-Mesa, Y., López-Ramos, J. C., Giménez-Llort, L., Revilla, S., Guerra, R.,
Gruart, A., et al. (2011). Physical exercise protects against Alzheimer’s disease in
3xTg-AD mice. J. Alzheimers Dis. 24, 421–454. doi: 10.3233/JAD-2011-101635
Giovannini, M. G. (2002). Double-label confocal microscopy of phosphorylated
protein kinases involved in long-term potentiation. Methods Enzymol. 345,
426–436. doi: 10.1016/S0076-6879(02)45035-5
Giovannini, M. G., Cerbai, F., Bellucci, A., Melani, C., Grossi, C., Bartolozzi, C.,
et al. (2008). Differential activation of mitogen-activated protein kinase
signalling pathways in the hippocampus of CRND8 transgenic mouse, a model
of Alzheimer’s disease. Neuroscience 153, 618–633. doi: 10.1016/j.neuroscience.
2008.02.061
Giovannini, M. G., Lana, D., and Pepeu, G. (2015). The integrated role of ACh, ERK
and mTOR in the mechanisms of hippocampal inhibitory avoidance memory.
Neurobiol. Learn. Mem. 119, 18–33. doi: 10.1016/j.nlm.2014.12.014
Gruart, A., López-Ramos, J. C., Muñoz, M. D., and Delgado-García, J. M. (2008).
Aged wild-type and APP, PS1, and APP + PS1 mice present similar deficits
in associative learning and synaptic plasticity independent of amyloid load.
Neurobiol. Dis. 30, 439–450. doi: 10.1016/j.nbd.2008.03.001
Hamby, M. E., and Sofroniew, M. V. (2010). Reactive astrocytes as therapeutic
targets for CNS disorders. Neurotherapeutics 7, 494–506. doi: 10.1016/j.nurt.
2010.07.003
Hamelin, L., Lagarde, J., Dorothée, G., Leroy, C., Labit, M., Comley, R. A., et al.
(2016). Early and protective microglial activation in Alzheimer’s disease: a
prospective study using 18F-DPA-714 PET imaging. Brain 139, 1252–1264.
doi: 10.1093/brain/aww017
Hamm, V., Héraud, C., Bott, J. B., Herbeaux, K., Strittmatter, C., Mathis, C., et al.
(2017). Differential contribution of APP metabolites to early cognitive deficits
in a TgCRND8 mouse model of Alzheimer’s disease. Sci. Adv. 24:e1601068.
doi: 10.1126/sciadv.1601068
Hanisch, U. K., and Kettenmann, H. (2007). Microglia: active sensor and versatile
effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387–1394.
doi: 10.1038/nn1997
Heneka, M. T., Carson, M. J., El Khoury, J., Landreth, G. E., Brosseron, F.,
Feinstein, D. L., et al. (2015). Neuroinflammation in Alzheimer’s disease. Lancet
Neurol. 14, 388–405. doi: 10.1016/S1474-4422(15)70016-5
Heneka, M. T., Rodriguez, J. J., and Verkhratsky, A. (2010). Neuroglia in
neurodegeneration. Brain Res. Rev. 63, 189–211. doi: 10.1016/j.brainresrev.
2009.11.004
Heppner, F. L., Ransohoff, R. M., and Becher, B. (2015). Immune attack: the
role of inflammation in Alzheimer disease. Nat. Rev. Neurosci. 16, 358–372.
doi: 10.1038/nrn3880
Hickman, S. E., Allison, E. K., and El Khoury, J. (2008). Microglial dysfunction and
defective beta-amyloid clearance pathways in aging Alzheimer’s disease mice.
J. Neurosci. 28, 8354–8360. doi: 10.1523/JNEUROSCI.0616-08.2008
Hu, X., Li, P., Guo, Y., Wang, H., Leak, R. K., Chen, S., et al. (2012).
Microglia/macrophage polarization dynamics reveal novel mechanism of injury
expansion after focal cerebral ischemia. Stroke 43, 3063–3070. doi: 10.1161/
STROKEAHA.112.659656
Hulse, R. E., Winterfield, J., Kunkler, P. E., and Kraig, R. P. (2001). Astrocytic
clasmatodendrosis in hippocampal organ culture. Glia 33, 169–179. doi: 10.
1002/1098-1136(200102)33:2<169::AID-GLIA1016>3.0.CO;2-B
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., and Barnes, C. L. (1984).
Alzheimer’s disease: cell-specific pathology isolates the hippocampal formation.
Science 225, 1168–1170. doi: 10.1126/science.6474172
Kerchner, G. A., Hess, C. P., Hammond-Rosenbluth, K. E., Xu, D., Rabinovici,
G. D., Kelley, D. A., et al. (2010). Hippocampal CA1 apical neuropil atrophy
in mild Alzheimer disease visualized with 7-T MRI. Neurology 75, 1381–1387.
doi: 10.1212/WNL.0b013e3181f736a1
Kettenmann, H., Kirchhoff, F., and Verkhratsky, A. (2013). Microglia: new
roles for the synaptic stripper. Neuron 77, 10–18. doi: 10.1016/j.neuron.2012.
12.023
Kristensen, B. W., Noraberg, J., and Zimmer, J. (2001). Comparison of excitotoxic
profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice
cultures. Brain Res. 917, 21–44. doi: 10.1016/S0006-8993(01)02900-6
Lahtinen, H., Autere, A. M., Paalasmaa, P., Lauri, S. E., and Kaila, K. (2001).
Post-insult activity is a major cause of delayed neuronal death in organotypic
Frontiers in Aging Neuroscience | www.frontiersin.org 21 November 2018 | Volume 10 | Article 372
fnagi-10-00372 November 9, 2018 Time: 16:26 # 22
Ugolini et al. Neurodegeneration Patterns in TgCRND8 Mice
hippocampal slices exposed to glutamate. Neuroscience 105, 131–137. doi: 10.
1016/S0306-4522(01)00168-3
Lana, D., Cerbai, F., Di Russo, J., Boscaro, F., Giannetti, A., Petkova-Kirova, P.,
et al. (2013). Hippocampal long term memory: effect of the cholinergic system
on local protein synthesis. Neurobiol. Learn. Mem. 106, 246–257. doi: 10.1016/
j.nlm.2013.09.013
Lana, D., Iovino, L., Nosi, D., Wenk, G. L., and Giovannini, M. G. (2016).
The neuron-astrocyte-microglia triad involvement in neuroinflammaging
mechanisms in the CA3 hippocampus of memory-impaired aged rats. Exp.
Gerontol. 83, 71–88. doi: 10.1016/j.exger.2016.07.011
Lana, D., Melani, A., Pugliese, A. M., Cipriani, S., Nosi, D., Pedata, F., et al.
(2014). The neuron-astrocyte-microglia triad in a rat model of chronic cerebral
hypoperfusion: protective effect of dipyridamole. Front. Aging Neurosci. 6:322.
doi: 10.3389/fnagi.2014.00322
Lana, D., Ugolini, F., Melani, A., Nosi, D., Pedata, F., and Giovannini, M. G.
(2017). The neuron-astrocyte-microglia triad in CA3 after chronic cerebral
hypoperfusion in the rat: protective effect of dipyridamole. Exp. Gerontol. 96,
46–62. doi: 10.1016/j.exger.2017.06.006
Latimer, C. S., Searcy, J. L., Bridges, M. T., Brewer, L. D., Popovic, J., Blalock,
E. M., et al. (2011). Reversal of glial and neurovascular markers of unhealthy
brain aging by exercise in middle-aged female mice. PLoS One 6:e26812. doi:
10.1371/journal.pone.0026812
Lawson, L. J., Perry, V. H., Dri, P., and Gordon, S. (1990). Heterogeneity in the
distribution and morphology of microglia in the normal adult mouse brain.
Neuroscience 39, 151–170. doi: 10.1016/0306-4522(90)90229-W
Li, X. G., Somogyi, P., Ylinen, A., and Buzsáki, G. (1994). The hippocampal CA3
network: an in vivo intracellular labeling study. J. Comp. Neurol. 339, 181–208.
doi: 10.1002/cne.903390204
Loane, D. J., and Kumar, A. (2016). Microglia in the TBI brain: the good, the bad,
and the dysregulated. Exp. Neurol. 275(Pt 3), 316–327. doi: 10.1016/j.expneurol.
2015.08.018
Lorente, and de Nó, R. (1934). Studies on the structure of the cerebral cortex.
II. Continuation of the study of the ammonic system. J. Psychol. Neurol. 46,
113–177.
Luccarini, I., Grossi, C., Traini, C., Fiorentini, A., Dami, T., and Casamenti, F.
(2012). Aβ plaque-associated glial reaction as a determinant of apoptotic
neuronal death and cortical gliogenesis: a study in APP mutant mice. Neurosci.
Lett. 506, 94–99. doi: 10.1016/j.neulet.2011.10.056
Mahar, I., Albuquerque, M. S., Mondragon-Rodriguez, S., Cavanagh, C., Davoli,
M. A., Chabot, J. G., et al. (2017). Phenotypic alterations in hippocampal NPY-
and PV-expressing interneurons in a presymptomatic transgenic mouse model
of Alzheimer’s disease. Front. Aging Neurosci. 19:327. doi: 10.3389/fnagi.2016.
00327
Mandrekar-Colucci, S., and Landreth, G. E. (2010). Microglia and inflammation in
Alzheimer’s disease. CNS Neurol. Disord. Drug Targets 9, 156–167. doi: 10.2174/
187152710791012071
Martens, U., Capito, B., and Wree, A. (1998). Septotemporal distribution
of [3H]MK-801, [3H]AMPA and [3H]Kainate binding sites in the rat
hippocampus. Anat. Embryol. 198, 195–204. doi: 10.1007/s004290050177
Masurkar, A. V. (2018). Towards a circuit-level understanding of hippocampal
CA1 dysfunction in Alzheimer’s disease across anatomical axes. J. Alzheimers
Dis. Parkinsonism 8:412. doi: 10.4172/2161-0460.1000412
Mercatelli, R., Lana, D., Bucciantini, M., Giovannini, M. G., Cerbai, F.,
Quercioli, F., et al. (2016). Clasmatodendrosis and β-amyloidosis in aging
hippocampus. FASEB J. 30, 1480–1491. doi: 10.1096/fj.15-275503
Michaud, J. P., and Rivest, S. (2015). Anti-inflammatory signaling in microglia
exacerbates Alzheimer’s disease-related pathology. Neuron 85, 450–452. doi:
10.1016/j.neuron.2015.01.021
Milligan, E. D., and Watkins, L. R. (2009). Pathological and protective roles of glia
in chronic pain. Nat. Rev. Neurosci. 10, 23–36. doi: 10.1038/nrn2533
Mueller, S. G., Schuff, N., Yaffe, K., Madison, C., Miller, B., and Weiner, M. W.
(2010). Hippocampal atrophy patterns in mild cognitive impairment and
Alzheimer’s disease. Hum. Brain Mapp. 31, 1339–1347. doi: 10.1002/hbm.20934
Nathan, C., Calingasan, N., Nezezon, J., Ding, A., Lucia, M. S., La Perle, K.,
et al. (2005). Protection from Alzheimer’s-like disease in the mouse by genetic
ablation of inducible nitric oxide synthase. J. Exp. Med. 202, 1163–1169. doi:
10.1084/jem.20051529
Neher, J. J., Neniskyte, U., and Brown, G. C. (2012). Primary phagocytosis of
neurons by inflamed microglia: potential roles in neurodegeneration. Front.
Pharmacol. 3:27. doi: 10.3389/fphar.2012.00027
Olabarria, M., Noristani, H. N., Verkhratsky, A., and Rodriguez, J. J. (2010).
Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal
model of Alzheimer’s disease. Glia 58, 831–838. doi: 10.1002/glia
Padurariu, M., Ciobica, A., Mavroudis, I., Fotiou, D., and Baloyannis, S. (2012).
Hippocampal neuronal loss in the CA1 and CA3 areas of Alzheimer’s disease
patients. Psychiatr. Danub. 24, 152–158.
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P.,
et al. (2011). Synaptic pruning by microglia is necessary for normal
brain development. Science 333, 1456–1458. doi: 10.1126/science.120
2529
Paresce, D. M., Chung, H., and Maxfield, F. R. (1997). Slow degradation of
aggregates of the Alzheimer’s disease amyloid beta-protein by microglial cells.
J. Biol. Chem. 272, 29390–29397. doi: 10.1074/jbc.272.46.29390
Park, K. J., Lee, S. H., Kim, T. I., Lee, H. W., Lee, C. H., Kim, E. H., et al. (2007).
A human scFv antibody against TRAIL receptor 2 induces autophagic cell
death in both TRAIL-sensitive and TRAIL-resistant cancer cells. Cancer Res.
67, 7327–7334. doi: 10.1158/0008-5472.CAN-06-4766
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R. III, Lafaille, J. J., et al.
(2013). Microglia promote learning-dependent synapse formation through
brain-derived neurotrophic factor. Cell 155, 1596–1609. doi: 10.1016/j.cell.2013.
11.030
Pekny, M., Wilhelmsson, U., and Pekna, M. (2014). The dual role of astrocyte
activation and reactive gliosis. Neurosci. Lett. 565, 30–38. doi: 10.1016/j.neulet.
2013.12.071
Penfield, W. (1928). A method of staining oligodendroglia and microglia
(combined method). Am. J. Pathol. 4, 153–157.
Perry, S. W., Dewhurst, S., Bellizzi, M. J., and Gelbard, H. A. (2002). Tumor
necrosis factor-alpha in normal and diseased brain: conflicting effects via
intraneuronal receptor crosstalk? J. Neurovirol. 8, 611–624. doi: 10.1080/
13550280290101021
Pfrieger, F. W. (2009). Roles of glial cells in synapse development. Cell. Mol. Life
Sci. 66, 2037–2047. doi: 10.1016/j.brainresrev.2009.11.002
Plescher, M., Seifert, G., Hansen, J. N., Bedner, P., Steinhäuser, C., and
Halle, A. (2018). Plaque-dependent morphological and electrophysiological
heterogeneity of microglia in an Alzheimer’s disease mouse model. Glia 66,
1464–1480. doi: 10.1002/glia.23318
Prendergast, M. A., Harris, B. R., Blanchard, J. A. II, Mayer, S., Gibson, D. A., and
Littleton, J. M. (2000a). In vitro effects of ethanol withdrawal and spermidine
on viability of hippocampus from male and female rat. Alcohol. Clin. Exp. Res.
24, 1855–1861. doi: 10.1111/j.1530-0277.2000.tb01990.x
Prendergast, M. A., Harris, B. R., Mayer, S., and Littleton, J. M. (2000b).
Chronic, but not acute, nicotine exposure attenuates ethanol withdrawal-
induced hippocampal damage in vitro. Alcohol. Clin. Exp. Res. 24, 1583–1592.
doi: 10.1111/j.1530-0277.2000.tb04578.x
Price, J. L., Ko, A. I., Wade, M. J., Tsou, S. K., McKeel, D. W., and Morris,
J. C. (2001). Neuron number in the entorhinal cortex and CA1 in preclinical
Alzheimer disease. Arch. Neurol. 58, 1395–1402. doi: 10.1001/archneur.58.9.
1395
Prinz, M., and Priller, J. (2014). Microglia and brain macrophages in the molecular
age: from origin to neuropsychiatric disease. Nat. Rev. Neurosci. 15, 300–312.
doi: 10.1038/nrn3722
Prinz, M., Priller, J., Sisodia, S. S., and Ransohoff, R. M. (2011). Heterogeneity
of CNS myeloid cells and their roles in neurodegeneration. Nat. Neurosci. 14,
1227–1235. doi: 10.1038/nn.2923
Protti, G. G., Gagliardi, R. J., Forte, W. C., and Sprovieri, S. R. (2013).
Interleukin-10 may protect against progressing injury during the acute phase of
ischemic stroke. Arq. Neuropsiquiatr. 71, 846–851. doi: 10.1590/0004-282X2013
0168
Rodriguez, J. J., Olabarria, M., Chvatal, A., and Verkhratsky, A. (2009). Astroglia in
dementia and Alzheimer’s disease. Cell Death Differ. 16, 378–385. doi: 10.1038/
cdd.2008.172
Rossler, M., Zarski, R., Bohl, J., and Ohm, T. G. (2002). Stage-dependent and
sector-specific neuronal loss in hippocampus during Alzheimer’s disease. Acta
Neuropathol. 103, 363–369. doi: 10.1007/s00401-001-0475-7
Frontiers in Aging Neuroscience | www.frontiersin.org 22 November 2018 | Volume 10 | Article 372
fnagi-10-00372 November 9, 2018 Time: 16:26 # 23
Ugolini et al. Neurodegeneration Patterns in TgCRND8 Mice
Safaiyan, S., Kannaiyan, N., Snaidero, N., Brioschi, S., Biber, K., Yona, S., et al.
(2016). Age-related myelin degradation burdens the clearance function of
microglia during aging. Nat. Neurosci. 19, 995–998. doi: 10.1038/nn.4325
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R.,
Yamasaki, R., et al. (2012). Microglia sculpt postnatal neural circuits in an
activity and complement-dependent manner. Neuron 74, 691–705. doi: 10.
1016/j.neuron.2012.03.026
Schafer, D. P., and Stevens, B. (2013). Phagocytic glial cells: sculpting synaptic
circuits in the developing nervous system. Curr. Opin. Neurobiol. 23, 1034–
1040. doi: 10.1016/j.conb.2013.09.012
Scheff, S. W., Price, D. A., Schmitt, F. A., DeKosky, S. T., and Mufson, E. J. (2007).
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive
impairment. Neurology 68, 1501–1508. doi: 10.1212/01.wnl.0000260698.465
17.8f
Schitine, C., Nogaroli, L., Costa, M. R., and Hedin-Pereira, C. (2015). Astrocyte
heterogeneity in the brain: from development to disease. Front. Cell. Neurosci.
9:76. doi: 10.3389/fncel.2015.00076
Small, S. A., Schobel, S. A., Buxton, R. B., Witter, M. P., and Barnes, C. A. (2011).
A pathophysiological framework of hippocampal dysfunction in ageing and
disease. Nat. Rev. Neurosci. 12, 585–601. doi: 10.1038/nrn3085
Sofroniew, M. V. (2009). Molecular dissection of reactive astrogliosis and glial scar
formation. Trends Neurosci. 32, 638–647. doi: 10.1016/j.tins.2009.08.002
Sofroniew, M. V., and Vinters, H. V. (2010). Astrocytes: biology and pathology.
Acta Neuropathol. 119, 7–35. doi: 10.1007/s00401-009-0619-8
Squire, L. R., Genzel, L., Wixted, J. T., and Morris, R. G. (2015). Memory
consolidation. Cold Spring Harb. Perspect. Biol. 7:a021766. doi: 10.1101/
cshperspect.a021766
Stepanichev, M. Y., Zdobnova, I. M., Zarubenko, I. I., Lazareva, N. A., and
Gulyaeva, N. V. (2006). Studies of the effects of central administration of beta-
amyloid peptide (25-35): pathomorphological changes in the Hippocampus
and impairment of spatial memory. Neurosci. Behav. Physiol. 36, 101–106.
doi: 10.1007/s11055-005-0167-1
Streit, W. J., Braak, H., Xue, Q. S., and Bechmann, I. (2009). Dystrophic (senescent)
rather than activated microglial cells are associated with tau pathology and
likely precede neurodegeneration in Alzheimer’s disease. Acta Neuropathol. 118,
475–485. doi: 10.1007/s00401-009-0556-6
Streit, W. J., Sammons, N. W., Kuhns, A. J., and Sparks, D. L. (2004). Dystrophic
microglia in the aging human brain. Glia 45, 208–212. doi: 10.1002/glia.10319
Suen, D. F., Norris, K. L., and Youle, R. J. (2008). Mitochondrial dynamics and
apoptosis. Genes Dev. 22, 1577–1590. doi: 10.1101/gad.1658508
Suenaga, J., Hu, X., Pu, H., Shi, Y., Hassan, S. H., Xu, M., et al. (2015). White
matter injury and microglia/macrophage polarization are strongly linked with
age-related long-term deficits in neurological function after stroke. Exp. Neurol.
272, 109–119. doi: 10.1016/j.expneurol.2015.03.021
Tan, Z. S., Beiser, A. S., Vasan, R. S., Roubenoff, R., Dinarello, C. A., Harris, T. B.,
et al. (2007). Inflammatory markers and the risk of Alzheimer disease: the
Framingham Study. Neurology 68, 1902–1908. doi: 10.1212/01.wnl.0000263217.
36439.da
Verkhratsky, A., Parpura, V., and Rodriguez, J. J. (2011). Where the thoughts
dwell: the physiology of neuronal-glial “diffuse neural net”. Brain Res. Rev. 66,
133–151. doi: 10.1016/j.brainresrev.2010.05.002
Verkhratsky, A., Rodríguez, J. J., and Parpura, V. (2013). Astroglia in neurological
diseases. Future Neurol. 8, 149–158. doi: 10.2217/fnl.12.90
Vilalta, A., and Brown, G. C. (2017). Neurophagy, the phagocytosis of live neurons
and synapses by glia, contributes to brain development and disease. FEBS J. 285,
3566–3575. doi: 10.1111/febs.14323
Vodovotz, Y., Lucia, M. S., Flanders, K. C., Chesler, L., Xie, Q. W., Smith, T. W.,
et al. (1996). Inducible nitric oxide synthase in tangle-bearing neurons of
patients with Alzheimer’s disease. J. Exp. Med. 184, 1425–1433. doi: 10.1084/
jem.184.4.1425
von Bernhardi, R. (2007). Glial cell dysregulation: a new perspective on Alzheimer
disease. Neurotox. Res. 12, 215–232. doi: 10.1007/bf03033906
Wake, H., Moorhouse, A. J., Miyamoto, A., and Nabekura, J. (2013). Microglia:
actively surveying and shaping neuronal circuit structure and function. Trends
Neurosci. 36, 209–217. doi: 10.1016/j.tins.2012.11.007
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., et al.
(2015). TREM2 lipid sensing sustains the microglial response in an Alzheimer’s
disease model. Cell 160, 1061–1071. doi: 10.1016/j.cell.2015.01.049
West, M. J., Coleman, P. D., Flood, D. G., and Troncoso, J. C. (1994). Differences
in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer’s
disease. Lancet 344, 769–772. doi: 10.1016/S0140-6736(94)92338-8
West, M. J., Kawas, C. H., Martin, L. J., and Troncoso, J. C. (2000). The CA1 region
of the human hippocampus is a hot spot in Alzheimer’s disease. Ann. N. Y. Acad.
Sci. 908, 255–259. doi: 10.1111/j.1749-6632.2000.tb06652.x
Whittington, M. A., and Little, H. J. (1993). Changes in voltage-operated calcium
channels modify ethanol withdrawal hyperexcitability in mouse hippocampal
sections. Exp. Physiol. 78, 347–370. doi: 10.1113/expphysiol.1993.sp003690
Yeh, C. Y., Vadhwana, B., Verkhratsky, A., and Rodriguez, J. J. (2011). Early
astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model
of Alzheimer’s disease. ASN Neuro 3, 271–279. doi: 10.1042/AN20110025
Zola-Morgan, S., Squire, L. R., and Amaral, D. G. (1986). Human amnesia and
the medial temporal region: enduring memory impairment following a bilateral
lesion limited to field CA1 of the hippocampus. J. Neurosci. 6, 2950–2967.
doi: 10.1523/JNEUROSCI.06-10-02950.1986
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2018 Ugolini, Lana, Nardiello, Nosi, Pantano, Casamenti and
Giovannini. This is an open-access article distributed under the terms of the Creative
Commons Attribution License (CC BY). The use, distribution or reproduction in
other forums is permitted, provided the original author(s) and the copyright owner(s)
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Aging Neuroscience | www.frontiersin.org 23 November 2018 | Volume 10 | Article 372
